col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


2806 Results       Page 2

[  < Back ]   [1]  [2] 
Frontiers Media SA: Frontiers in Immunology
  original article Date Title Authors   All Authors
2001 [GO] 2022―Jan―28 Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein Yunwen Zhang, Zhengrong Yang, Mingyuan Tang, Hao Li, Tian Tang, Guilian Li, et al. (+4)
2002 [GO] 2022―Jan―28 SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Marina L. García-Vaquero, Quentin Lecrevisse, Raquel Herrero, Antonio Ferruelo, et al. (+6)
2003 [GO] 2022―Jan―28 Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern Daniel López
2004 [GO] 2022―Jan―28 Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy Paige K. Marty, Virginia P. Van Keulen, Courtney L. Erskine, Maleeha Shah, Amber Hummel, Michael Stachowitz, et al. (+11)
2005 [GO] 2022―Jan―27 Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study Anna Beltrame, Pedro Salguero, Emanuela Rossi, Ana Conesa, Lucia Moro, Laura Rachele Bettini, et al. (+10)
2006 [GO] 2022―Jan―27 Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review Pamir Atagündüz, Gökhan Keser, Mehmet Soy
2007 [GO] 2022―Jan―27 T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients Yizhe Li, Jian Hu, Yongsi Wang, Dongdong Liu, Yaling Shi, Jiaqi Zhang, et al. (+11)
2008 [GO] 2022―Jan―27 Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort Shihan Zhang, Ke Xu, Chuchu Li, Lu Zhou, Xiaoxiao Kong, Jiefu Peng, et al. (+6)
2009 [GO] 2022―Jan―27 Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study Yan Chen, Jianfeng Xie, Wenjuan Wu, Shusheng Li, Yu Hu, Ming Hu, et al. (+19)
2010 [GO] 2022―Jan―27 Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Rachel M.Y. Cheong, Anusha Yellapragada, Wey Y. Wong, et al. (+5)
2011 [GO] 2022―Jan―27 Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts Carlota Dobaño, Selena Alonso, Marta Vidal, Alfons Jiménez, Rocío Rubio, Rebeca Santano, et al. (+29)
2012 [GO] 2022―Jan―27 A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pedro J. Sánchez-Cordón, David Astorgano, Joanna Luczkowiak, et al. (+4)
2013 [GO] 2022―Jan―27 SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity Haolin Liu, Pengcheng Wei, John W. Kappler, Philippa Marrack, Gongyi Zhang
2014 [GO] 2022―Jan―26 Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Michael DePietro, Marc Salzberg
2015 [GO] 2022―Jan―26 SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron Alessio Mazzoni, Anna Vanni, Michele Spinicci, Manuela Capone, Giulia Lamacchia, Lorenzo Salvati, et al. (+14)
2016 [GO] 2022―Jan―25 Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies Karsten Suhre, Hina Sarwath, Rudolf Engelke, Muhammad Umar Sohail, Soo Jung Cho, William Whalen, et al. (+4)
2017 [GO] 2022―Jan―25 Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination Krystallenia Paniskaki, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, Sarah Skrzypczyk, et al. (+15)
2018 [GO] 2022―Jan―24 Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies Masaud Shah, Hyun Goo Woo
2019 [GO] 2022―Jan―24 Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? Federica Saponaro, Maria Franzini, Chukwuma Okoye, Rachele Antognoli, Beatrice Campi, Marco Scalese, et al. (+7)
2020 [GO] 2022―Jan―24 The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs Hoang Oanh Nguyen, Tiziana Schioppa, Laura Tiberio, Fabrizio Facchinetti, Gino Villetti, Maurizio Civelli, et al. (+8)
2021 [GO] 2022―Jan―21 mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2 Yingqi Jin, Chen Hou, Yonghao Li, Kang Zheng, Chuan Wang
2022 [GO] 2022―Jan―21 Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients Makoto Kurano, Hiroko Ohmiya, Yoshiro Kishi, Jun Okada, Yuki Nakano, Rin Yokoyama, et al. (+10)
2023 [GO] 2022―Jan―20 Swine Enteric Coronaviruses (PEDV, TGEV, and PDCoV) Induce Divergent Interferon-Stimulated Gene Responses and Antigen Presentation in Porcine Intestinal Enteroids Lingdan Yin, Xiang Liu, Dongmei Hu, Yi Luo, Guozhong Zhang, Pinghuang Liu
2024 [GO] 2022―Jan―20 Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities Hamed Fouladseresht, Atefe Ghamar Talepoor, Nahid Eskandari, Marzieh Norouzian, Behrooz Ghezelbash, Mohammad Reza Beyranvand, et al. (+4)
2025 [GO] 2022―Jan―19 Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment André F. Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, Harjot K. Singh, Shashi N. Kapadia, Luca Vincenzo Cappelli, et al. (+4)
2026 [GO] 2022―Jan―19 CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects Laura Esparcia-Pinedo, Pedro Martínez-Fleta, Noelia Ropero, Paula Vera-Tomé, Hugh T. Reyburn, José M. Casasnovas, et al. (+7)
2027 [GO] 2022―Jan―19 Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial Simon Jochum, Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Udo Eichenlaub, et al. (+2)
2028 [GO] 2022―Jan―19 Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2 Robert Markewitz, David Juhl, Daniela Pauli, Siegfried Görg, Ralf Junker, Jan Rupp, et al. (+13)
2029 [GO] 2022―Jan―19 The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency Isabella Quinti, Franco Locatelli, Rita Carsetti
2030 [GO] 2022―Jan―18 Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Leung, Emily S. J. Edwards, Anna E. S. Brooks
2031 [GO] 2022―Jan―18 Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2 Marlene Plüß, Kemal Mese, Johannes T. Kowallick, Andreas Schuster, Désirée Tampe, Björn Tampe
2032 [GO] 2022―Jan―18 SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection Susan R. Conway, Christopher A. Lazarski, Naomi E. Field, Mariah Jensen-Wachspress, Haili Lang, Vaishnavi Kankate, et al. (+14)
2033 [GO] 2022―Jan―18 CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2 Congling Qiu, Chanchan Xiao, Zhigang Wang, Guodong Zhu, Lipeng Mao, Xiongfei Chen, et al. (+13)
2034 [GO] 2022―Jan―17 Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response Elisa Pesce, Nicola Manfrini, Chiara Cordiglieri, Spartaco Santi, Alessandra Bandera, Andrea Gobbini, et al. (+17)
2035 [GO] 2022―Jan―17 Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients Fatemeh Saheb Sharif-Askari, Swati Goel, Narjes Saheb Sharif-Askari, Shirin Hafezi, Saba Al Heialy, Mahmood Yaseen Hachim, et al. (+10)
2036 [GO] 2022―Jan―17 B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications Marco Iannetta, Doriana Landi, Gaia Cola, Laura Campogiani, Vincenzo Malagnino, Elisabetta Teti, et al. (+13)
2037 [GO] 2022―Jan―14 The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19 Carla Usai, Joseph M. Gibbons, Corinna Pade, Wenhao Li, Sabina R. M. Jacobs, Áine McKnight, et al. (+2)
2038 [GO] 2022―Jan―14 The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19 Gang Xu, Furong Qi, Haiyan Wang, Yu Liu, Xin Wang, Rongrong Zou, et al. (+5)
2039 [GO] 2022―Jan―14 Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients Yufei Mo, Kelvin Kai-Wang To, Runhong Zhou, Li Liu, Tianyu Cao, Haode Huang, et al. (+12)
2040 [GO] 2022―Jan―14 Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease Progression Min Zhao, Zhen Liu, Fei Shao, Wenjing Zhou, Zhu Chen, Pengyan Xia, et al. (+2)
2041 [GO] 2022―Jan―14 In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor Faez Iqbal Khan, Fakhrul Hassan, Dakun Lai
2042 [GO] 2022―Jan―14 Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16- Monocytes From COVID-19 Patients Silvia Lucena Lage, Eduardo Pinheiro Amaral, Kerry L. Hilligan, Elizabeth Laidlaw, Adam Rupert, Sivaranjani Namasivayan, et al. (+12)
2043 [GO] 2022―Jan―14 Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2 Wael Bahnan, Sebastian Wrighton, Martin Sundwall, Anna Bläckberg, Olivia Larsson, Urban Höglund, et al. (+16)
2044 [GO] 2022―Jan―13 Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration Andrea Henriques-Pons, Daniela Gois Beghini, Vanessa dos Santos Silva, Samuel Iwao Horita, Fabrício Alves Barbosa da Silva
2045 [GO] 2022―Jan―13 COVID-19 Disease and Dermatomyositis: A Mini-Review Jie Qian, Hui Xu
2046 [GO] 2022―Jan―13 Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2 Renata Fioravanti Tarabini, Mauricio Menegatti Rigo, André Faustino Fonseca, Felipe Rubin, Rafael Bellé, Lydia E Kavraki, et al. (+3)
2047 [GO] 2022―Jan―12 Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Hiroaki Mon, Keita Sato, Kosuke Oyama, et al. (+19)
2048 [GO] 2022―Jan―12 DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model Levi A. Tamming, Diana Duque, Anh Tran, Wanyue Zhang, Annabelle Pfeifle, Emmanuel Laryea, et al. (+16)
2049 [GO] 2022―Jan―12 Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study Thais G. Moreira, Kimble T. F. Matos, Giovana S. De Paula, Thais M. M. Santana, Raquel G. Da Mata, Fernando C. Pansera, et al. (+13)
2050 [GO] 2022―Jan―11 Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women Kee Thai Yeo, Wan Ni Chia, Chee Wah Tan, Chengsi Ong, Joo Guan Yeo, Jinyan Zhang, et al. (+8)
2051 [GO] 2022―Jan―11 A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19 Pedro Martínez-Fleta, Paula Vera-Tomé, María Jiménez-Fernández, Silvia Requena, Emilia Roy-Vallejo, Ancor Sanz-García, et al. (+12)
2052 [GO] 2022―Jan―11 Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection Kyu-Young Sim, Gwang-Hoon Ko, So-Eun Bae, Kyu Yeong Choi, Jung Sup Lee, Byeong C. Kim, et al. (+3)
2053 [GO] 2022―Jan―10 Evidence of Microglial Immune Response Following Coronavirus PHEV Infection of CNS Jing Zhang, Zi Li, Huijun Lu, Junchao Shi, Rui Gao, Ying Ma, et al. (+5)
2054 [GO] 2022―Jan―10 In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
2055 [GO] 2022―Jan―10 Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra, Emily Long, Amruta Pise, Hallison Rodrigues, et al. (+11)
2056 [GO] 2022―Jan―10 The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis Xinwei Huang, Huazheng Liang, Hong Zhang, Li Tian, Peilin Cong, Tingmei Wu, et al. (+11)
2057 [GO] 2022―Jan―07 A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis Yi-Zi Xie, Chen-Wen Peng, Zu-Qing Su, Hui-Ting Huang, Xiao-Hong Liu, Shao-Feng Zhan, Xiu-Fang Huang
2058 [GO] 2022―Jan―06 Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals Sergio Gil-Manso, Iria Miguens Blanco, Rocío López-Esteban, Diego Carbonell, Luis Andrés López-Fernández, Lori West, et al. (+2)
2059 [GO] 2022―Jan―06 Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters Kyle L. O’Donnell, Chad S. Clancy, Amanda J. Griffin, Kyle Shifflett, Tylisha Gourdine, Tina Thomas, et al. (+3)
2060 [GO] 2022―Jan―06 Comprehensive Analysis of CD4+ T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II You-Seok Hyun, Yong-Hun Lee, Hyeong-A Jo, In-Cheol Baek, Sun-Mi Kim, Hyun-Jung Sohn, Tai-Gyu Kim
2061 [GO] 2022―Jan―05 Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination Yair Zlotnik, Avi Gadoth, Ibrahim Abu-Salameh, Anat Horev, Rosa Novoa, Gal Ifergane
2062 [GO] 2022―Jan―05 Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide Nathalie Vanderheijden, Annelies Stevaert, Jiexiong Xie, Xiaolei Ren, Cyril Barbezange, Sam Noppen, et al. (+9)
2063 [GO] 2022―Jan―05 Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis Liwei Zhang, Mingxing Li, Zhiwei Wang, Peng Sun, Shunbo Wei, Cong Zhang, et al. (+2)
2064 [GO] 2022―Jan―05 Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era Leila Abdelhamid, Xin M. Luo
2065 [GO] 2022―Jan―04 Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response Wenye Xu, Yingzhi Liu, Xuan Zou, Huanle Luo, Weihua Wu, Junjie Xia, et al. (+5)
2066 [GO] 2022―Jan―03 Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks Guadalein Tanunliong, Aaron Liu, Rohit Vijh, Tamara Pidduck, Jesse Kustra, Ana Citlali Márquez, et al. (+9)
2067 [GO] 2022―Jan―03 Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities Xu Li, Manik Garg, Tingting Jia, Qijun Liao, Lifang Yuan, Mao Li, et al. (+10)
2068 [GO] 2022―Jan―03 SARS-CoV-2 Variants, Vaccines, and Host Immunity Priyal Mistry, Fatima Barmania, Juanita Mellet, Kimberly Peta, Adéle Strydom, Ignatius M. Viljoen, et al. (+3)
2069 [GO] 2021―Dec―24 Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques Patrick J. Madden, Muhammad S. Arif, Mark E. Becker, Michael D. McRaven, Ann M. Carias, Ramon Lorenzo-Redondo, et al. (+16)
2070 [GO] 2021―Dec―23 Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies Ryan M. Pace, Janet E. Williams, Kirsi M. Järvinen, Courtney L. Meehan, Melanie A. Martin, Sylvia H. Ley, et al. (+19)
2071 [GO] 2021―Dec―23 Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment Nayoun Kim, Jong-Min Lee, Eun-Jee Oh, Dong Wook Jekarl, Dong-Gun Lee, Keon-Il Im, Seok-Goo Cho
2072 [GO] 2021―Dec―23 Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders Bahaa Abu-Raya, Shabir A. Madhi, Saad B. Omer, Gayatri Amirthalingam, Michelle L. Giles, Katie L. Flanagan, et al. (+9)
2073 [GO] 2021―Dec―23 Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection Ilias Christodoulou, Ruyan Rahnama, Jonas W. Ravich, Jaesung Seo, Sergey N. Zolov, Andrew N. Marple, et al. (+2)
2074 [GO] 2021―Dec―23 SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene Youwei Zhu, Zhaoyang Zhang, Jia Song, Weizhou Qian, Xiangqian Gu, Chaoyong Yang, et al. (+3)
2075 [GO] 2021―Dec―22 Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19 Keiji Kuba, Tomokazu Yamaguchi, Josef M. Penninger
2076 [GO] 2021―Dec―22 Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection Long-Fang Chen, Cheng-De Yang, Xiao-Bing Cheng
2077 [GO] 2021―Dec―22 Role of Exercise Intensity on Th1/Th2 Immune Modulations During the COVID-19 Pandemic Rashmi Supriya, Yang Gao, Yaodong Gu, Julien S. Baker
2078 [GO] 2021―Dec―22 Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting Ziwei Li, Tiandan Xiang, Boyun Liang, Hui Deng, Hua Wang, Xuemei Feng, et al. (+14)
2079 [GO] 2021―Dec―21 A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques Megan A. O’Connor, Jesse H. Erasmus, Samantha Randall, Jacob Archer, Thomas B. Lewis, Brieann Brown, et al. (+8)
2080 [GO] 2021―Dec―20 Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 Sibylle C. Mellinghoff, Kanika Vanshylla, Christine Dahlke, Marylyn M. Addo, Oliver A. Cornely, Florian Klein, et al. (+4)
2081 [GO] 2021―Dec―20 Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies Murad Abusukhun, Martin S. Winkler, Stefan Pöhlmann, Onnen Moerer, Konrad Meissner, Björn Tampe, et al. (+4)
2082 [GO] 2021―Dec―20 Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals Jéromine Klingler, Gregory S. Lambert, Vincenza Itri, Sean Liu, Juan C. Bandres, Gospel Enyindah-Asonye, et al. (+12)
2083 [GO] 2021―Dec―20 Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study Geng Wang, Qian Wang, Yeming Wang, Changzheng Liu, Linghang Wang, Hong Chen, et al. (+11)
2084 [GO] 2021―Dec―17 Crystal Structures of Bat and Human Coronavirus ORF8 Protein Ig-Like Domain Provide Insights Into the Diversity of Immune Responses Xiaoxue Chen, Zhechong Zhou, Chunliu Huang, Ziliang Zhou, Sisi Kang, Zhaoxia Huang, et al. (+12)
2085 [GO] 2021―Dec―17 Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents Hing Wai Tsang, Gilbert T. Chua, Kelvin K. W. To, Joshua S. C. Wong, Wenwei Tu, Janette S. Y. Kwok, et al. (+14)
2086 [GO] 2021―Dec―17 An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection Peter A. van der Ley, Afshin Zariri, Elly van Riet, Dinja Oosterhoff, Corine P. Kruiswijk
2087 [GO] 2021―Dec―16 Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19 Daniel Elieh Ali Komi, Yaghoub Rahimi, Rahim Asghari, Reza Jafari, Javad Rasouli, Mehdi Mohebalizadeh, et al. (+4)
2088 [GO] 2021―Dec―16 Innate Receptors Expression by Lung Nociceptors: Impact on COVID-19 and Aging Carlos H. Hiroki, Nicole Sarden, Mortaza F. Hassanabad, Bryan G. Yipp
2089 [GO] 2021―Dec―16 Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children Chengliang Yang, Hedi Zhao, Scott J. Tebbutt
2090 [GO] 2021―Dec―16 Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús-González, Carlos Daniel Cordero-Rivera, Carlos Noe Farfan-Morales, Juan Fidel Osuna-Ramos, Gustavo Martínez-Mier, et al. (+5)
2091 [GO] 2021―Dec―15 The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial Nazanin Majidi, Faezeh Rabbani, Somayeh Gholami, Maryam Gholamalizadeh, Fatemeh BourBour, Samira Rastgoo, et al. (+10)
2092 [GO] 2021―Dec―15 Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, Behzad Aria, Behzad Hemati, Farhang Fatehi, et al. (+5)
2093 [GO] 2021―Dec―15 Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Hatem Zayed, Sang-Soo Lee
2094 [GO] 2021―Dec―14 A Recent Update on Advanced Molecular Diagnostic Techniques for COVID-19 Pandemic: An Overview Akanksha Roberts, Raghuraj Singh Chouhan, Deepshikha Shahdeo, Narlawar Sagar Shrikrishna, Veerbhan Kesarwani, Milena Horvat, Sonu Gandhi
2095 [GO] 2021―Dec―13 Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population Farhan S. Cyprian, Muhammad Suleman, Ibrahim Abdelhafez, Asmma Doudin, Ibn Mohammed Masud Danjuma, Fayaz Ahmad Mir, et al. (+12)
2096 [GO] 2021―Dec―13 A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants Sisi Shan, Chee Keng Mok, Shuyuan Zhang, Jun Lan, Jizhou Li, Ziqing Yang, et al. (+13)
2097 [GO] 2021―Dec―13 Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19 Jasmin D. Haslbauer, Carl Zinner, Anna K. Stalder, Jan Schneeberger, Thomas Menter, Stefano Bassetti, et al. (+4)
2098 [GO] 2021―Dec―13 The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis Jiting Wang, Yue Tong, Duo Li, Jun Li, Yaling Li
2099 [GO] 2021―Dec―09 Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations Haijun Wang, Zili Zhang, Junfen Zhou, Shuqing Han, Zhenyu Kang, Haoyu Chuang, et al. (+11)
2100 [GO] 2021―Dec―09 Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome Agnes S. Meidert, Stefanie Hermann, Florian Brandes, Benedikt Kirchner, Dominik Buschmann, Jean-Noël Billaud, et al. (+6)
2101 [GO] 2021―Dec―09 Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together Lin Zhang, Josh Poorbaugh, Michael Dougan, Peter Chen, Robert L. Gottlieb, Gregory Huhn, et al. (+11)
2102 [GO] 2021―Dec―09 Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis Tyler J. Loftus, Ricardo Ungaro, Marvin Dirain, Philip A. Efron, Monty B. Mazer, Kenneth E. Remy, et al. (+6)
2103 [GO] 2021―Dec―09 SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination Yudi T. Pinilla, Constanze Heinzel, Lena-Fabienne Caminada, Douglas Consolaro, Meral Esen, Peter G. Kremsner, et al. (+3)
2104 [GO] 2021―Dec―09 SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals Prithivi Chellamuthu, Aaron N. Angel, Melanie A. MacMullan, Nicholas Denny, Aubree Mades, Marilisa Santacruz, et al. (+12)
2105 [GO] 2021―Dec―09 A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern Shahbaz Ahmed, Mohammad Suhail Khan, Savitha Gayathri, Randhir Singh, Sahil Kumar, Unnatiben Rajeshbhai Patel, et al. (+21)
2106 [GO] 2021―Dec―09 Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case Kevin M. Vannella, Cihan Oguz, Sydney R. Stein, Stefania Pittaluga, Esra Dikoglu, Arjun Kanwal, et al. (+20)
2107 [GO] 2021―Dec―07 IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis Chiara Cioccarelli, Ricardo Sánchez-Rodríguez, Roberta Angioni, Francisca C. Venegas, Nicole Bertoldi, Fabio Munari, et al. (+3)
2108 [GO] 2021―Dec―07 Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression Manon Ruffin, Jeanne Bigot, Claire Calmel, Julia Mercier, Maëlle Givelet, Justine Oliva, et al. (+6)
2109 [GO] 2021―Dec―07 SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-ĸB Activation Jie Xia, Wenqi Tang, Jiangmei Wang, Dengming Lai, Qi Xu, Ruoqiong Huang, et al. (+5)
2110 [GO] 2021―Dec―07 A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains Fengxia Gao, Jingjing Huang, Tingting Li, Chao Hu, Meiying Shen, Song Mu, et al. (+11)
2111 [GO] 2021―Dec―06 Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection Aifen Lin, Wei-Hua Yan
2112 [GO] 2021―Dec―06 Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19 Thi Nhu Mai Tran, Bruce Pearson May, Trong Thuan Ung, Mai Khoi Nguyen, Thi Thuy Trang Nguyen, Van Long Dinh, et al. (+27)
2113 [GO] 2021―Dec―06 Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19 Lowell Ling, Zigui Chen, Grace Lui, Chun Kwok Wong, Wai Tat Wong, Rita W. Y. Ng, et al. (+6)
2114 [GO] 2021―Dec―02 Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients Sara Caldrer, Cristina Mazzi, Milena Bernardi, Marco Prato, Niccolò Ronzoni, Paola Rodari, et al. (+3)
2115 [GO] 2021―Dec―02 Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort Georg Beilhack, Rossella Monteforte, Florian Frommlet, Martina Gaggl, Robert Strassl, Andreas Vychytil
2116 [GO] 2021―Dec―02 Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants Wei-Shuo Lin, I-Chen Chen, Hui-Chen Chen, Yi-Chien Lee, Suh-Chin Wu
2117 [GO] 2021―Dec―01 Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases Kaushik Sen, Sudeshna Datta, Arup Ghosh, Atimukta Jha, Abdul Ahad, Sanchari Chatterjee, et al. (+10)
2118 [GO] 2021―Dec―01 Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection Margherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Mahesh Agarwal, Jenifer Bear, Robert Burns, et al. (+7)
2119 [GO] 2021―Dec―01 Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease Ji Yeon Lee, Jee Young Lee, Jae-Hoon Ko, Miri Hyun, Hyun Ah Kim, Seongcheol Cho, et al. (+4)
2120 [GO] 2021―Dec―01 Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern Antonio J. Martín-Galiano, Francisco Díez-Fuertes, Michael J. McConnell, Daniel López
2121 [GO] 2021―Dec―01 m6A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients Xiangmin Qiu, Xiaoliang Hua, Qianyin Li, Qin Zhou, Juan Chen
2122 [GO] 2021―Dec―01 Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost Amar K. Garg, Soumya Mittal, Pranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit
2123 [GO] 2021―Dec―01 Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines Waleed H. Mahallawi, Walaa A. Mumena
2124 [GO] 2021―Dec―01 The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape Dandan Tian, Yanhong Sun, Jianming Zhou, Qing Ye
2125 [GO] 2021―Dec―01 Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities Modjtaba Emadi-Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, Mahnaz Norouzi, Zahra Joz-Abbasalian
2126 [GO] 2021―Dec―01 COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study Jian Wu, Quanman Li, Clifford Silver Tarimo, Meiyun Wang, Jianqin Gu, Wei Wei, et al. (+4)
2127 [GO] 2021―Dec―01 COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis Clio Bilotta, Giulio Perrone, Valeria Adelfio, Giovanni Francesco Spatola, Maria Laura Uzzo, Antonina Argo, Stefania Zerbo
2128 [GO] 2021―Nov―30 Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs Mark C. Howell, Ryan Green, Andrew R. McGill, Roukiah M. Kahlil, Rinku Dutta, Shyam S. Mohapatra, Subhra Mohapatra
2129 [GO] 2021―Nov―30 Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature Bruno Fattizzo, Raffaella Pasquale, Valentina Bellani, Wilma Barcellini, Austin G. Kulasekararaj
2130 [GO] 2021―Nov―30 Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination Hamad Ali, Abdulmohsen Alterki, Sardar Sindhu, Barrak Alahmad, Maha Hammad, Salman Al-Sabah, et al. (+13)
2131 [GO] 2021―Nov―30 Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions Sang Won Lee, Ji-Yong Moon, Sun-Kyung Lee, Hyun Lee, SeolHwa Moon, Sung Jun Chung, et al. (+7)
2132 [GO] 2021―Nov―30 Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis Cheng Zhang, Yi-Gang Feng, Chiwing Tam, Ning Wang, Yibin Feng
2133 [GO] 2021―Nov―30 Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis Sisse R. Ostrowski, Ole S. Søgaard, Martin Tolstrup, Nina B. Stærke, Jens Lundgren, Lars Østergaard, Anne-Mette Hvas
2134 [GO] 2021―Nov―22 Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines Yandi Zhang, Jo-Lewis Banga Ndzouboukou, Mengze Gan, Xiaosong Lin, Xionglin Fan
2135 [GO] 2021―Nov―19 Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests Yue Zhou, Xuelian Liao, Xiangrong Song, Min He, Fei Xiao, Xiaodong Jin, et al. (+6)
2136 [GO] 2021―Nov―19 Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases Javier Castillo-Olivares, David A. Wells, Matteo Ferrari, Andrew C. Y. Chan, Peter Smith, Angalee Nadesalingam, et al. (+22)
2137 [GO] 2021―Nov―19 Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals Jackwee Lim, Kia Joo Puan, Liang Wei Wang, Karen Wei Weng Teng, Chiew Yee Loh, Kim Peng Tan, et al. (+27)
2138 [GO] 2021―Nov―19 Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization Jin Wang, Cheng Guo, Lin Cai, Conghui Liao, Huaimin Yi, Qianlin Li, et al. (+6)
2139 [GO] 2021―Nov―18 Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge Yaiza Senent, Susana Inogés, Ascensión López-Díaz de Cerio, Andres Blanco, Arantxa Campo, Francisco Carmona-Torre, et al. (+8)
2140 [GO] 2021―Nov―18 The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity Carlos del Fresno, Juan García-Arriaza, Sarai Martínez-Cano, Ignacio Heras-Murillo, Aitor Jarit-Cabanillas, Joaquín Amores-Iniesta, et al. (+14)
2141 [GO] 2021―Nov―18 Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Hisaaki Kawabata, Dominika Bielak, Weina Sun, et al. (+6)
2142 [GO] 2021―Nov―18 MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants Sua Lee, Shina Jang, Jihoon Kang, Soo Bin Park, Young Woo Han, Hyemi Nam, et al. (+13)
2143 [GO] 2021―Nov―17 COVID-19, Pre-Eclampsia, and Complement System Chiara Agostinis, Alessandro Mangogna, Andrea Balduit, Azin Aghamajidi, Giuseppe Ricci, Uday Kishore, Roberta Bulla
2144 [GO] 2021―Nov―16 Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People Julie Demaret, Bénédicte Corroyer-Simovic, Enagnon Kazali Alidjinou, Anne Goffard, Jacques Trauet, Sophie Miczek, et al. (+15)
2145 [GO] 2021―Nov―15 XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants Bernard Vanhove, Stéphane Marot, Ray T. So, Benjamin Gaborit, Gwénaëlle Evanno, Isabelle Malet, et al. (+11)
2146 [GO] 2021―Nov―11 Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19 Anna E. Spiering, Teun J. de Vries
2147 [GO] 2021―Nov―11 Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo Ruby A. Escobedo, Dhiraj K. Singh, Deepak Kaushal
2148 [GO] 2021―Nov―11 Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents Berislav Bošnjak, Ivan Odak, Joana Barros-Martins, Inga Sandrock, Swantje I. Hammerschmidt, Marc Permanyer, et al. (+22)
2149 [GO] 2021―Nov―11 Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1 Theodore J. Cory, Russell S. Emmons, Johnathan R. Yarbro, Kierstin L. Davis, Brandt D. Pence
2150 [GO] 2021―Nov―11 Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations Damiano Buratto, Abhishek Saxena, Qun Ji, Guang Yang, Sergio Pantano, Francesco Zonta
2151 [GO] 2021―Nov―11 Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination Tiphany Chrun, Emmanuel A. Maze, Eleni Vatzia, Veronica Martini, Basudev Paudyal, Matthew D. Edmans, et al. (+7)
2152 [GO] 2021―Nov―11 Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19 Hayder M. Al-kuraishy, Ali Ismail Al-Gareeb, Gomaa Mostafa-Hedeab, Keneth Iceland Kasozi, Gerald Zirintunda, Akhmed Aslam, et al. (+3)
2153 [GO] 2021―Nov―10 Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19 Hao Zhang, Bo Shao, Qin Dang, Zhuang Chen, Quanbo Zhou, Hong Luo, et al. (+2)
2154 [GO] 2021―Nov―10 Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients Sergey G. Shcherbak, Anna Yu Anisenkova, Sergei V. Mosenko, Oleg S. Glotov, Alexander N. Chernov, Svetlana V. Apalko, et al. (+6)
2155 [GO] 2021―Nov―10 SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS Weiling Li, Jialu Qiao, Qiang You, Shan Zong, Qian Peng, Yuchen Liu, et al. (+5)
2156 [GO] 2021―Nov―10 High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders Dalila Mele, Anna Calastri, Eugenia Maiorano, Antonella Cerino, Michele Sachs, Barbara Oliviero, et al. (+8)
2157 [GO] 2021―Nov―10 Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals Charly Gilbert, Caroline Lefeuvre, Laurence Preisser, Adeline Pivert, Raffaella Soleti, Simon Blanchard, et al. (+4)
2158 [GO] 2021―Nov―09 A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels Denis A. Kleymenov, Evgeniia N. Bykonia, Liubov I. Popova, Elena P. Mazunina, Vladimir A. Gushchin, Liudmila V. Kolobukhina, et al. (+11)
2159 [GO] 2021―Nov―09 Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine Felipe Melo-González, Jorge A. Soto, Liliana A. González, Jorge Fernández, Luisa F. Duarte, Bárbara M. Schultz, et al. (+25)
2160 [GO] 2021―Nov―08 SARS-CoV-2 and HIV-1: Should HIV-1-Infected Individuals in Sub-Saharan Africa Be Considered a Priority Group for the COVID-19 Vaccines? Wilson Lewis Mandala, Michael K. P. Liu
2161 [GO] 2021―Nov―05 The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies Camila Hartmann, Anna Flavia Ribeiro dos Santos Miggiolaro, Jarbas da Silva Motta, Lucas Baena Carstens, Caroline Busatta Vaz De Paula, Sarah Fagundes Grobe, et al. (+6)
2162 [GO] 2021―Nov―05 SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems Anne G. Savitt, Samantha Manimala, Tiara White, Marina Fandaros, Wei Yin, Huiquan Duan, et al. (+6)
2163 [GO] 2021―Nov―05 Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape Fuxing Lou, Maochen Li, Zehan Pang, Lin Jiang, Lin Guan, Lili Tian, et al. (+3)
2164 [GO] 2021―Nov―03 COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge Anna Furlan, Gabriella Forner, Ludovica Cipriani, Elisa Vian, Roberto Rigoli, Filippo Gherlinzoni, Piergiorgio Scotton
2165 [GO] 2021―Nov―03 COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads Yarden Golan, Mary Prahl, Arianna G. Cassidy, Caryl Gay, Alan H. B. Wu, Unurzul Jigmeddagva, et al. (+12)
2166 [GO] 2021―Nov―03 Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection Gabriel Siracusano, Chiara Brombin, Claudia Pastori, Federica Cugnata, Maddalena Noviello, Elena Tassi, et al. (+13)
2167 [GO] 2021―Nov―03 Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections Liyana Ahmad
2168 [GO] 2021―Nov―02 SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation Ida Jarlhelt, Sif Kaas Nielsen, Camilla Xenia Holtermann Jahn, Cecilie Bo Hansen, Laura Pérez-Alós, Anne Rosbjerg, et al. (+3)
2169 [GO] 2021―Nov―02 Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses Emelie Marklund, Susannah Leach, Kristina Nyström, Anna Lundgren, Jan-Åke Liljeqvist, Staffan Nilsson, et al. (+4)
2170 [GO] 2021―Nov―01 Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia Nina Nurarifah, Herwindo Pudjo Brahmantyo, Shinta Oktya Wardhani, Djoko Heri Hermanto, Putu Moda Arsana
2171 [GO] 2021―Nov―01 COVID-19 Mechanisms in the Human Body-What We Know So Far Ashutosh Kumar, Ravi K. Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, et al. (+10)
2172 [GO] 2021―Nov―01 Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains Clemens Grimm, Steffen Dickel, Julian Grundmann, Didier Payen, Julie Schanz, Andreas Erich Zautner, et al. (+3)
2173 [GO] 2021―Oct―29 The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications Ming Zheng
2174 [GO] 2021―Oct―29 Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections Georg von Massow, Steve Oh, Alan Lam, Kenth Gustafsson
2175 [GO] 2021―Oct―29 The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes Guoxing Tang, Min Huang, Ying Luo, Wei Liu, Qun Lin, Liyan Mao, et al. (+5)
2176 [GO] 2021―Oct―28 Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19 Jafar Sarif, Deblina Raychaudhuri, Ranit D’Rozario, Purbita Bandopadhyay, Praveen Singh, Priyanka Mehta, et al. (+20)
2177 [GO] 2021―Oct―28 Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model Judy D. Day, Soojin Park, Benjamin L. Ranard, Harinder Singh, Carson C. Chow, Yoram Vodovotz
2178 [GO] 2021―Oct―28 Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study Panteleimon Charitos, Ingmar A. F. M. Heijnen, Adrian Egli, Stefano Bassetti, Marten Trendelenburg, Michael Osthoff
2179 [GO] 2021―Oct―28 Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections Katina D. Hulme, Ellesandra C. Noye, Kirsty R. Short, Larisa I. Labzin
2180 [GO] 2021―Oct―27 Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19 Sanqi An, Yueqi Li, Yao Lin, Jiemei Chu, Jinming Su, Qiuli Chen, et al. (+7)
2181 [GO] 2021―Oct―26 Case Report: The Carotid Body in COVID-19: Histopathological and Virological Analyses of an Autopsy Case Series Andrea Porzionato, Aron Emmi, Martina Contran, Elena Stocco, Silvia Riccetti, Alessandro Sinigaglia, et al. (+3)
2182 [GO] 2021―Oct―26 Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency Sabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, Angelo Iacobino, Raffaela Teloni, Maria Laura De Angelis, et al. (+22)
2183 [GO] 2021―Oct―25 The Omic Insights on Unfolding Saga of COVID-19 Arvinpreet Kaur, Mehak Chopra, Mahak Bhushan, Sonal Gupta, Hima Kumari P, Narmadhaa Sivagurunathan, et al. (+20)
2184 [GO] 2021―Oct―22 Cardiac Fibrosis Is a Risk Factor for Severe COVID-19 Julian Mustroph, Julian Hupf, Maria J. Baier, Katja Evert, Christoph Brochhausen, Katharina Broeker, et al. (+6)
2185 [GO] 2021―Oct―22 Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis Amirali Karimi, Parnian Shobeiri, Arutha Kulasinghe, Nima Rezaei
2186 [GO] 2021―Oct―21 Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements Paulina García-González, Fabián Tempio, Camila Fuentes, Consuelo Merino, Leonardo Vargas, Valeska Simon, et al. (+18)
2187 [GO] 2021―Oct―21 Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route Koen van de Ven, Harry van Dijken, Lisa Wijsman, Angéla Gomersbach, Tanja Schouten, Jolanda Kool, et al. (+5)
2188 [GO] 2021―Oct―20 Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19 Collins N. Khwatenge, Marquette Pate, Laura C. Miller, Yongming Sang
2189 [GO] 2021―Oct―20 Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19 Zachary M. Holliday, Alexander P. Earhart, Mohammed M. Alnijoumi, Armin Krvavac, Lee-Ann H. Allen, Adam G. Schrum
2190 [GO] 2021―Oct―20 Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress Omar Graciano-Machuca, Geannyne Villegas-Rivera, Iván López-Pérez, José Macías-Barragán, Sonia Sifuentes-Franco
2191 [GO] 2021―Oct―20 Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment Yonggang Zhou, Xiuxiu Xu, Haiming Wei
2192 [GO] 2021―Oct―20 Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening System Yunjiao He, Jing Qu, Lan Wei, Shumin Liao, Nianzhen Zheng, Yingzi Liu, et al. (+13)
2193 [GO] 2021―Oct―20 Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2 Sudhanshu Agrawal, Jon Salazar, Thu Michelle Tran, Anshu Agrawal
2194 [GO] 2021―Oct―17 When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak Yassine Taoufik, Marie-Ghislaine de Goër de Herve, Stéphanie Corgnac, Antoine Durrbach, Fathia Mami-Chouaib
2195 [GO] 2021―Oct―16 Diphtheria And Tetanus Vaccination History Is Associated With Lower Odds of COVID-19 Hospitalization Jennifer Monereo-Sánchez, Jurjen J. Luykx, Justo Pinzón-Espinosa, Geneviève Richard, Ehsan Motazedi, Lars T. Westlye, et al. (+2)
2196 [GO] 2021―Oct―14 Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential Ikram Hussain, Gabriel Liu Yuan Cher, Muhammad Abbas Abid, Muhammad Bilal Abid
2197 [GO] 2021―Oct―13 Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape Kavitha Mukund, Priya Nayak, Chethan Ashokkumar, Sohail Rao, Jose Almeda, Monica M. Betancourt-Garcia, et al. (+2)
2198 [GO] 2021―Oct―13 Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients Michael Z. Zulu, Suhas Sureshchandra, Amanda N. Pinski, Brianna Doratt, Weining Shen, Ilhem Messaoudi
2199 [GO] 2021―Oct―13 Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can Álvaro Tamayo-Velasco, María Jesús Peñarrubia Ponce, Francisco Javier Álvarez, Hugo Gonzalo-Benito, Ignacio de la Fuente, Sonia Pérez-González, et al. (+16)
2200 [GO] 2021―Oct―13 Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis Nadim Sharif, Khalid J. Alzahrani, Shamsun Nahar Ahmed, Shuvra Kanti Dey
2201 [GO] 2021―Oct―13 The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines Renee W. Y. Chan, Shaojun Liu, Jonathan Y. Cheung, Joseph G. S. Tsun, Kate C. Chan, Kathy Y. Y. Chan, et al. (+3)
2202 [GO] 2021―Oct―13 Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure Melanie R. Neeland, Samantha Bannister, Vanessa Clifford, Jill Nguyen, Kate Dohle, Isabella Overmars, et al. (+18)
2203 [GO] 2021―Oct―12 The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients Huzeyfe Kulu, Mustafa Atasoy, Kemal Özyurt, Marcus Maurer, Atıl Avcı, Muhammet Reşat Akkuş, Ragıp Ertaş
2204 [GO] 2021―Oct―10 COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks Mankgopo Magdeline Kgatle, Ismaheel Opeyemi Lawal, Gabriel Mashabela, Tebatso Moshoeu Gillian Boshomane, Palesa Caroline Koatale, Phetole Walter Mahasha, et al. (+7)
2205 [GO] 2021―Oct―10 Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2 Xunyan Ye, Laura S. Angelo, Erin G. Nicholson, Obinna P. Iwuchukwu, Wanderson Cabral de Rezende, Anubama Rajan, et al. (+16)
2206 [GO] 2021―Oct―10 Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children Constanze Heinzel, Yudi T. Pinilla, Käthe Elsner, Evelyn Friessinger, Benjamin Mordmüller, Peter G. Kremsner, et al. (+3)
2207 [GO] 2021―Oct―10 Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief Tor Kristian Andersen, Johanna Bodin, Fredrik Oftung, Bjarne Bogen, Siri Mjaaland, Gunnveig Grødeland
2208 [GO] 2021―Oct―09 Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants Rafael Bayarri-Olmos, Ida Jarlhelt, Laust Bruun Johnsen, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, et al. (+8)
2209 [GO] 2021―Oct―07 A Systematic Review and Meta-Analysis of Inpatient Mortality Associated With Nosocomial and Community COVID-19 Exposes the Vulnerability of Immunosuppressed Adults Mark J. Ponsford, Tom J. C. Ward, Simon M. Stoneham, Clare M. Dallimore, Davina Sham, Khalid Osman, et al. (+4)
2210 [GO] 2021―Oct―07 Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys Celeste Coleman, Lara A. Doyle-Meyers, Kasi E. Russell-Lodrigue, Nadia Golden, Breanna Threeton, Kejing Song, et al. (+7)
2211 [GO] 2021―Oct―04 Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days Sergio Gil-Manso, Diego Carbonell, Luis López-Fernández, Iria Miguens, Roberto Alonso, Ismael Buño, et al. (+4)
2212 [GO] 2021―Oct―04 COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases Silvana Valdebenito, Simon Bessis, Djillali Annane, Geoffroy Lorin de la Grandmaison, Elisabeth Cramer-Bordé, Brendan Prideaux, et al. (+2)
2213 [GO] 2021―Oct―04 Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, et al. (+12)
2214 [GO] 2021―Oct―04 Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies Donato Amodio, Alessandra Ruggiero, Mayla Sgrulletti, Chiara Pighi, Nicola Cotugno, Chiara Medri, et al. (+20)
2215 [GO] 2021―Oct―04 Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target Konstantinos Ntatsoulis, Theodoros Karampitsakos, Eliza Tsitoura, Elli-Anna Stylianaki, Alexios N. Matralis, Argyrios Tzouvelekis, et al. (+2)
2216 [GO] 2021―Oct―04 Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions Mai M. Abdelmoaty, Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, Vikas Kumar, et al. (+7)
2217 [GO] 2021―Oct―01 Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics Sriram Kumar, Duygu Merve Çalışkan, Josua Janowski, Aileen Faist, Beate Claudine Gisela Conrad, Julius Lange, et al. (+2)
2218 [GO] 2021―Oct―01 Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS Zhiheng Xu, Yongbo Huang, Jianmeng Zhou, Xiumei Deng, Weiqun He, Xiaoqing Liu, et al. (+3)
2219 [GO] 2021―Oct―01 Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines Andrea Picchianti Diamanti, Maria Manuela Rosado, Emanuele Nicastri, Giorgio Sesti, Claudio Pioli, Bruno Laganà
2220 [GO] 2021―Oct―01 Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2 Roshan Kumar Roy, Uttam Sharma, Mishi Kaushal Wasson, Aklank Jain, Md. Imtaiyaz Hassan, Hridayesh Prakash
2221 [GO] 2021―Sep―30 Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination Samy Hakroush, Björn Tampe
2222 [GO] 2021―Sep―30 Identifying Risk Factors for Secondary Infection Post-SARS-CoV-2 Infection in Patients With Severe and Critical COVID-19 Mingquan Guo, Menglu Gao, Jing Gao, Tengfei Zhang, Xin Jin, Jian Fan, et al. (+4)
2223 [GO] 2021―Sep―30 Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword Li Yin Tan, Thamil Vaani Komarasamy, Vinod RMT Balasubramaniam
2224 [GO] 2021―Sep―30 Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report Martin Kongsbak-Wismann, Fatima A. H. Al-Jaberi, Jonas Damgård Schmidt, Mustafa Ghanizada, Cecilie Bo Hansen, Daniel Villalba Lopez, et al. (+7)
2225 [GO] 2021―Sep―30 Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults Maria Raffaella Petrara, Francesco Bonfante, Paola Costenaro, Anna Cantarutti, Francesco Carmona, Elena Ruffoni, et al. (+13)
2226 [GO] 2021―Sep―29 Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions Izabela Siemińska, Kazimierz Węglarczyk, Marcin Surmiak, Dorota Kurowska-Baran, Marek Sanak, Maciej Siedlar, Jarek Baran
2227 [GO] 2021―Sep―29 COVID-19 Among Patients With Inflammatory Rheumatic Diseases Sinem Nihal Esatoglu, Koray Tascilar, Hakan Babaoğlu, Cemal Bes, Berna Yurttas, Servet Akar, et al. (+17)
2228 [GO] 2021―Sep―29 BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents Bernd Jahrsdörfer, Dorit Fabricius, Judith Scholz, Carolin Ludwig, Aline Grempels, Ramin Lotfi, et al. (+3)
2229 [GO] 2021―Sep―29 Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, et al. (+23)
2230 [GO] 2021―Sep―28 MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals Erick C. Castelli, Mateus V. de Castro, Michel S. Naslavsky, Marilia O. Scliar, Nayane S. B. Silva, Heloisa S. Andrade, et al. (+23)
2231 [GO] 2021―Sep―28 Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine Annalisa Ciabattini, Gabiria Pastore, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Elena Pettini, et al. (+8)
2232 [GO] 2021―Sep―27 Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis Adriana Albini, Luana Calabrone, Valentina Carlini, Nadia Benedetto, Michele Lombardo, Antonino Bruno, Douglas M. Noonan
2233 [GO] 2021―Sep―27 SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans David Forgacs, Hyesun Jang, Rodrigo B. Abreu, Hannah B. Hanley, Jasper L. Gattiker, Alexandria M. Jefferson, Ted M. Ross
2234 [GO] 2021―Sep―27 Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants Lok Bahadur Shrestha, Nicodemus Tedla, Rowena A. Bull
2235 [GO] 2021―Sep―27 Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, Roberta Reniè, Rachele Bigi, Giulia Pellicciari, et al. (+6)
2236 [GO] 2021―Sep―25 Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol Roos S. G. Sablerolles, Abraham Goorhuis, Corine H. GeurtsvanKessel, Rory D. de Vries, Anke L. W. Huckriede, Marion P. G. Koopmans, et al. (+8)
2237 [GO] 2021―Sep―25 Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach Veerbhan Kesarwani, Rupal Gupta, Ramesh Raju Vetukuri, Sandeep Kumar Kushwaha, Sonu Gandhi
2238 [GO] 2021―Sep―25 α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants Jintao Zou, Haiming Jing, Xiaoli Zhang, Yiheng Liu, Zhuo Zhao, Lianli Duan, et al. (+9)
2239 [GO] 2021―Sep―23 Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study Haifeng Hou, Huan Yang, Pengcheng Liu, Changwu Huang, Meng Wang, Yuejin Li, et al. (+8)
2240 [GO] 2021―Sep―23 Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Carlos A. Labarrere, Ghassan S. Kassab
2241 [GO] 2021―Sep―23 A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants Niklas Vesper, Yaneth Ortiz, Frauke Bartels-Burgahn, Jianying Yang, Kathrin de la Rosa, Matthias Tenbusch, et al. (+6)
2242 [GO] 2021―Sep―23 Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody Shuai Yue, Zhirong Li, Yao Lin, Yang Yang, Mengqi Yuan, Zhiwei Pan, et al. (+16)
2243 [GO] 2021―Sep―22 Will Auranofin Become a Golden New Treatment Against COVID-19? Karine Sonzogni-Desautels, Momar Ndao
2244 [GO] 2021―Sep―22 Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report Karen R. Sherwood, David D. M. Nicholl, Franz Fenninger, Vivian Wu, Paaksum Wong, Vince Benedicto, et al. (+13)
2245 [GO] 2021―Sep―22 Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine Jinyoung Yang, Jae-Hoon Ko, Jin Yang Baek, Jinyeong Hong, Soyoung Ha, Beomki Lee, et al. (+7)
2246 [GO] 2021―Sep―21 Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective Madhusudhanan Narasimhan, Lenin Mahimainathan, Jungsik Noh, Alagarraju Muthukumar
2247 [GO] 2021―Sep―21 Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen Min Jiang, Gaiping Zhang, Hongliang Liu, Peiyang Ding, Yunchao Liu, Yuanyuan Tian, et al. (+2)
2248 [GO] 2021―Sep―20 Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU Lorena Vigón, Javier García-Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, María Castillo de la Osa, et al. (+10)
2249 [GO] 2021―Sep―20 LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications Behazine Combadière, Lucille Adam, Noëlline Guillou, Paul Quentric, Pierre Rosenbaum, Karim Dorgham, et al. (+12)
2250 [GO] 2021―Sep―20 SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril) Tlili Barhoumi, Bandar Alghanem, Hayat Shaibah, Fatmah A. Mansour, Hassan S. Alamri, Maaged A. Akiel, et al. (+2)
2251 [GO] 2021―Sep―17 Nutritional Immunity, Zinc Sufficiency, and COVID-19 Mortality in Socially Similar European Populations Samer Singh, Amita Diwaker, Brijesh P. Singh, Rakesh K. Singh
2252 [GO] 2021―Sep―17 Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia Anas A. Khan, Ahmed A. Alahmari, Yasir Almuzaini, Fahad Alamri, Yousef Mohammad Alsofayan, Alhanouf Aburas, et al. (+6)
2253 [GO] 2021―Sep―17 Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals Liina Tserel, Piia Jõgi, Paul Naaber, Julia Maslovskaja, Annika Häling, Ahto Salumets, et al. (+10)
2254 [GO] 2021―Sep―17 IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant Yonas Bekele, Yongjun Sui, Jay A. Berzofsky
2255 [GO] 2021―Sep―16 On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers Aarón Vázquez-Jiménez, Ugo Enrique Avila-Ponce De León, Meztli Matadamas-Guzman, Erick Andrés Muciño-Olmos, Yoscelina E. Martínez-López, Thelma Escobedo-Tapia, Osbaldo Resendis-Antonio
2256 [GO] 2021―Sep―16 Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge Elizabeth Gabitzsch, Jeffrey T. Safrit, Mohit Verma, Adrian Rice, Peter Sieling, Lise Zakin, et al. (+19)
2257 [GO] 2021―Sep―16 Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection Dawei Cui, Yuan Tang, Qi Jiang, Daixi Jiang, Yun Zhang, Yan Lv, et al. (+5)
2258 [GO] 2021―Sep―16 A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine Sonia Jangra, Jeffrey J. Landers, Raveen Rathnasinghe, Jessica J. O’Konek, Katarzyna W. Janczak, Marilia Cascalho, et al. (+5)
2259 [GO] 2021―Sep―15 The Effects of COVID-19 on the Placenta During Pregnancy Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, Mark C. Allenby, Sajad Razavi Bazaz, Majid E. Warkiani, et al. (+3)
2260 [GO] 2021―Sep―14 Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion Oliver F. Wirz, Katharina Röltgen, Bryan A. Stevens, Suchitra Pandey, Malaya K. Sahoo, Lorna Tolentino, et al. (+12)
2261 [GO] 2021―Sep―14 ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients Andrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, Chiara Agrati, Concetta Castilletti, Silvia Meschi, et al. (+22)
2262 [GO] 2021―Sep―10 Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality Federica Defendi, Corentin Leroy, Olivier Epaulard, Giovanna Clavarino, Antoine Vilotitch, Marion Le Marechal, et al. (+10)
2263 [GO] 2021―Sep―09 Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19 Juan Du, Lirong Wei, Guoli Li, Mingxi Hua, Yao Sun, Di Wang, et al. (+8)
2264 [GO] 2021―Sep―08 Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19 Alexandra L. Morrison, Sally Sharpe, Andrew D. White, Mark Bodman-Smith
2265 [GO] 2021―Sep―08 Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report Liru Qiu, Ji Zhang, Yafei Huang, Gen Chen, Zhishui Chen, Changsheng Ming, et al. (+2)
2266 [GO] 2021―Sep―08 Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes Jiram Torres-Ruiz, Alfredo Pérez-Fragoso, José Luis Maravillas-Montero, Luis Llorente, Nancy R. Mejía-Domínguez, José Carlos Páez-Franco, et al. (+11)
2267 [GO] 2021―Sep―08 Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology Margarita Villar, José Miguel Urra, Francisco J. Rodríguez-del-Río, Sara Artigas-Jerónimo, Natalia Jiménez-Collados, Elisa Ferreras-Colino, et al. (+5)
2268 [GO] 2021―Sep―08 Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm Carolina Boni, Davide Cavazzini, Angelo Bolchi, Marzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al. (+4)
2269 [GO] 2021―Sep―07 Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers Evgeny Knyazev, Stepan Nersisyan, Alexander Tonevitsky
2270 [GO] 2021―Sep―07 From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling Filippo Castiglione, Debashrito Deb, Anurag P. Srivastava, Pietro Liò, Arcangelo Liso
2271 [GO] 2021―Sep―06 The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients Fang Liu, Hong Liu, Wen-Yan Yu, Zhan Liu, Xia Zhang, Yi Wang, et al. (+4)
2272 [GO] 2021―Sep―06 SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic Johanna Sjöwall, Mohammad Azharuddin, Martina Frodlund, Yuming Zhang, Laura Sandner, Charlotte Dahle, et al. (+2)
2273 [GO] 2021―Sep―06 Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections Byoung-Jun Kim, Hyein Jeong, Hyejun Seo, Mi-Hyun Lee, Hyun Mu Shin, Bum-Joon Kim
2274 [GO] 2021―Sep―04 Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study Olga Krysko, Elena Kondakova, Olga Vershinina, Elena Galova, Anna Blagonravova, Ekaterina Gorshkova, et al. (+4)
2275 [GO] 2021―Sep―04 Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort Maria J. Pons, Barbara Ymaña, Ana Mayanga-Herrera, Yolanda Sáenz, Lydia Alvarez-Erviti, Salyoc Tapia-Rojas, et al. (+4)
2276 [GO] 2021―Sep―04 The Binary Model of Chronic Diseases Applied to COVID-19 Zeev Elkoshi
2277 [GO] 2021―Sep―04 Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 Jiajia Xie, Chengchao Ding, Jun He, Yuqing Zhang, Shuangshuang Ni, Xiangyu Zhang, et al. (+9)
2278 [GO] 2021―Sep―04 Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study Jamil A. Al-Mughales, Tareq J. Al-Mughales, Omar I. Saadah
2279 [GO] 2021―Sep―04 Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era Keda Yang, Guangfu Wen, Jinpeng Wang, Siming Zhou, Wacili Da, Yan Meng, et al. (+2)
2280 [GO] 2021―Sep―04 Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals Joseph G. Casian, Aaron N. Angel, Ronell Lopez, Cedie Bagos, Melanie A. MacMullan, Mindy L. Bui, et al. (+5)
2281 [GO] 2021―Sep―04 The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity Sonia Tejedor Vaquero, Leire de Campos-Mata, José María Ramada, Pilar Díaz, Juan Navarro-Barriuso, Clara Ribas-Llaurado, et al. (+5)
2282 [GO] 2021―Aug―31 COVID-19 Immunobiology: Lessons Learned, New Questions Arise Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. Gorgoulis, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas
2283 [GO] 2021―Aug―24 Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19 Yang Liu, Yankang Wu, Bing Liu, Youpeng Zhang, Dan San, Yu Chen, et al. (+8)
2284 [GO] 2021―Aug―24 The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis Miao Zou, Xiaoyun Su, Luoying Wang, Xingcheng Yi, Yue Qiu, Xirui Yin, et al. (+4)
2285 [GO] 2021―Aug―24 SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients Elise M. N. Ferré, Monica M. Schmitt, Sebastian Ochoa, Lindsey B. Rosen, Elana R. Shaw, Peter D. Burbelo, et al. (+8)
2286 [GO] 2021―Aug―23 Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report Mafalda De Rienzo, Maria Laura Foddai, Laura Conti, Chiara Mandoj, Stefano Iaboni, Ilenia Saladini, et al. (+10)
2287 [GO] 2021―Aug―23 Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach Patil Pranita Uttamrao, Chakkarai Sathyaseelan, L. Ponoop Prasad Patro, Thenmalarchelvi Rathinavelan
2288 [GO] 2021―Aug―20 Cytokine Signature Associated With Disease Severity in COVID-19 Jing Guo, Shuting Wang, He Xia, Ding Shi, Yu Chen, Shufa Zheng, et al. (+17)
2289 [GO] 2021―Aug―19 Serological Testing for COVID-19, Immunological Surveillance, and Exploration of Protective Antibodies Luis A. Peroni, Jessica M. Toscaro, Camila Canateli, Celisa C. C. Tonoli, Renata R. de Olivera, Celso E. Benedetti, et al. (+12)
2290 [GO] 2021―Aug―19 Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients Yaolin Guo, Tianyi Li, Xinyi Xia, Bin Su, Hanping Li, Yingmei Feng, et al. (+7)
2291 [GO] 2021―Aug―19 Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients Baolin Liao, Zhao Chen, Peiyan Zheng, Linghua Li, Jianfen Zhuo, Fang Li, et al. (+18)
2292 [GO] 2021―Aug―19 Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities Chang-Feng Chu, Florian Sabath, Silvia Fibi-Smetana, Shan Sun, Rupert Öllinger, Elfriede Noeßner, et al. (+7)
2293 [GO] 2021―Aug―18 Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19 Ellinor I. Peerschke, Alisa Valentino, Rachel J. So, Scott Shulman,   Ravinder
2294 [GO] 2021―Aug―18 Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women Suriya Rehman, Vijaya Ravinayagam, Insha Nahvi, Hanan Aldossary, Maha Al-Shammari, Mai Saad Al Amiri, et al. (+2)
2295 [GO] 2021―Aug―17 Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies Chengchao Ding, Jun He, Xiangyu Zhang, Chengcheng Jiang, Yong Sun, Yuqing Zhang, et al. (+6)
2296 [GO] 2021―Aug―16 Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity Jun Wu, Bo-Yun Liang, Yao-Hui Fang, Hua Wang, Xiao-Li Yang, Shu Shen, et al. (+12)
2297 [GO] 2021―Aug―13 Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain Linda Francistiová, Adrián Klepe, Géza Curley, Károly Gulya, András Dinnyés, Kata Filkor
2298 [GO] 2021―Aug―12 Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study Thais G. Moreira, Kimble T. F. Matos, Giovana S. De Paula, Thais M. M. Santana, Raquel G. Da Mata, Fernando C. Pansera, et al. (+12)
2299 [GO] 2021―Aug―12 DAMPening COVID-19 Severity by Attenuating Danger Signals Luis A. Silva-Lagos, Janesh Pillay, Matijs van Meurs, Alexandra Smink, Peter H. J. van der Voort, Paul de Vos
2300 [GO] 2021―Aug―10 Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections Ying-yi Luan, Cheng-hong Yin, Yong-ming Yao
2301 [GO] 2021―Aug―10 COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial Chiara Agrati, Serena Di Cosimo, Daniela Fenoglio, Giovanni Apolone, Fabio Ciceri, Gennaro Ciliberto, et al. (+12)
2302 [GO] 2021―Aug―10 SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage Mohsen Karami Fath, Abolfazl Jahangiri, Mahmoud Ganji, Fatemeh Sefid, Zahra Payandeh, Zahra Sadat Hashemi, et al. (+6)
2303 [GO] 2021―Aug―09 The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men Gizem Kilic, Ozlem Bulut, Martin Jaeger, Rob ter Horst, Valerie A. C. M. Koeken, Simone J. C. F. M. Moorlag, et al. (+5)
2304 [GO] 2021―Aug―06 Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study Shengjie Li, Yichao Qiu, Li Tang, Zhujian Wang, Wenjun Cao, Xingtao Zhou, Xinghuai Sun
2305 [GO] 2021―Aug―05 Corrigendum: Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children Ming-Ren Chen, Ho-Chang Kuo, Yann-Jinn Lee, Hsin Chi, Sung Chou Li, Hung-Chang Lee, Kuender D. Yang
2306 [GO] 2021―Aug―05 BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Ashleigh L. Fell, Rachel M. Y. Cheong, Wey Y. Wong, et al. (+3)
2307 [GO] 2021―Aug―04 Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19 Philipp Jörrißen, Paula Schütz, Matthias Weiand, Richard Vollenberg, Inga Marie Schrempf, Kevin Ochs, et al. (+4)
2308 [GO] 2021―Aug―02 Long Noncoding RNAs as Emerging Regulators of COVID-19 Qinzhi Yang, Fang Lin, Yanan Wang, Min Zeng, Mao Luo
2309 [GO] 2021―Aug―02 Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase Jens Ringel, Anja Ramlow, Christopher Bock, Ahmed Sheriff
2310 [GO] 2021―Aug―02 Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study Jiao Liu, Yanfei Shen, Zhenliang Wen, Qianghong Xu, Zhixiong Wu, Huibin Feng, et al. (+15)
2311 [GO] 2021―Jul―30 Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19 Jijing Shi, Jianglin Zhou, Xiaochang Zhang, Wei Hu, Jin-Fang Zhao, Shengqi Wang, et al. (+2)
2312 [GO] 2021―Jul―29 Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients Jiaqi Zhang, Dongzi Lin, Kui Li, Xiangming Ding, Lin Li, Yuntao Liu, et al. (+11)
2313 [GO] 2021―Jul―29 Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients Xiaolu Li, Deqing Yin, Yanyan Yang, Chunhua Bi, Zhibin Wang, Guangren Ma, et al. (+4)
2314 [GO] 2021―Jul―29 Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity Antonella Scaglione, Silvana Opp, Alicia Hurtado, Ziyan Lin, Christine Pampeno, Maria G. Noval, et al. (+3)
2315 [GO] 2021―Jul―28 Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses Wenjiang Zheng, Hui Wu, Chengxin Liu, Qian Yan, Ting Wang, Peng Wu, et al. (+3)
2316 [GO] 2021―Jul―28 Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments Sangiliyandi Gurunathan, Min Hee Kang, Jin-Hoi Kim
2317 [GO] 2021―Jul―28 Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma Xiaoli Zhou, Ya-Na Zhou, Ashaq Ali, Cuiqin Liang, Zhiqin Ye, Xiaomin Chen, et al. (+13)
2318 [GO] 2021―Jul―28 Swine Dendritic Cell Response to Porcine Reproductive and Respiratory Syndrome Virus: An Update Jesús Hernández, Yanli Li, Enric Mateu
2319 [GO] 2021―Jul―27 Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography Jiong Wang, Dongmei Li, Qian Zhou, Alexander Wiltse, Martin S. Zand
2320 [GO] 2021―Jul―27 SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects Orianne Constant, Jonathan Barthelemy, Karine Bolloré, Edouard Tuaillon, Fabien Gosselet, Christine Chable-Bessia, et al. (+5)
2321 [GO] 2021―Jul―26 Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity Johannes Schetelig, Falk Heidenreich, Henning Baldauf, Sarah Trost, Bose Falk, Christian Hoßbach, et al. (+16)
2322 [GO] 2021―Jul―26 Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies Qiaozhen Ye, Shan Lu, Kevin D. Corbett
2323 [GO] 2021―Jul―26 Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study Laura Sánchez García, Natalia Gómez-Torres, Fernando Cabañas, Raquel González-Sánchez, Manuela López-Azorín, M. Teresa Moral-Pumarega, et al. (+6)
2324 [GO] 2021―Jul―26 The Ability of Porcine Reproductive and Respiratory Syndrome Virus Isolates to Induce Broadly Reactive Neutralizing Antibodies Correlates With In Vivo Protection Francisco Javier Martínez-Lobo, Francisco Díez-Fuertes, Isabel Simarro, José M. Castro, Cinta Prieto
2325 [GO] 2021―Jul―23 Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19 Po-Ku Chen, Joung-Liang Lan, Po-Hao Huang, Jye-Lin Hsu, Ching-Kun Chang, Ni Tien, et al. (+2)
2326 [GO] 2021―Jul―23 Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19 Xavier Solanich, Gardenia Vargas-Parra, Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Arnau Antolí, et al. (+13)
2327 [GO] 2021―Jul―23 CAR Macrophages for SARS-CoV-2 Immunotherapy Wenyan Fu, Changhai Lei, Zetong Ma, Kewen Qian, Tian Li, Jian Zhao, Shi Hu
2328 [GO] 2021―Jul―23 CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro Minh Tuyet Ma, Saiaditya Badeti, Chih-Hsiung Chen, James Kim, Alok Choudhary, Bill Honnen, et al. (+10)
2329 [GO] 2021―Jul―21 Monocytes and Macrophages in COVID-19 Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
2330 [GO] 2021―Jul―20 Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study Danrong Shi, Tianhao Weng, Jie Wu, Chunyan Dai, Rui Luo, Keda Chen, et al. (+13)
2331 [GO] 2021―Jul―19 Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level Hannah C. Copley, Loren Gragert, Andrew R. Leach, Vasilis Kosmoliaptsis
2332 [GO] 2021―Jul―16 High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals Jeremy W. Prokop, Nicholas L. Hartog, Dave Chesla, William Faber, Chanise P. Love, Rachid Karam, et al. (+24)
2333 [GO] 2021―Jul―15 Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19 Nathalie Acevedo, Jose Miguel Escamilla-Gil, Héctor Espinoza, Ronald Regino, Jonathan Ramírez, Lucila Florez de Arco, et al. (+3)
2334 [GO] 2021―Jul―15 Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients Xiangyun Teng, Jiaqi Zhang, Yaling Shi, Yuntao Liu, Yanqing Yang, Jinyong He, et al. (+9)
2335 [GO] 2021―Jul―14 Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells Matthew J. Dean, Juan B. Ochoa, Maria Dulfary Sanchez-Pino, Jovanny Zabaleta, Jone Garai, Luis Del Valle, et al. (+20)
2336 [GO] 2021―Jul―14 The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion? Zhihui Wang, Ming Zhou, Zhenfang Fu, Ling Zhao
2337 [GO] 2021―Jul―14 Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19 Alessandra Oliva, Maria Claudia Miele, Federica Di Timoteo, Massimiliano De Angelis, Vera Mauro, Raissa Aronica, et al. (+6)
2338 [GO] 2021―Jul―13 The Many Faces of JAKs and STATs Within the COVID-19 Storm Alice H. Grant, Armando Estrada, Yoshira M. Ayala-Marin, America Y. Alvidrez-Camacho, Georgialina Rodriguez, Elisa Robles-Escajeda, et al. (+3)
2339 [GO] 2021―Jul―13 Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects Eleonora Gallerani, Davide Proietto, Beatrice Dallan, Marco Campagnaro, Salvatore Pacifico, Valentina Albanese, et al. (+6)
2340 [GO] 2021―Jul―12 Erratum: Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
2341 [GO] 2021―Jul―12 Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Franziska Sotzny, Sandra Bauer, Christian Drosten, et al. (+3)
2342 [GO] 2021―Jul―12 Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine Jules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, Maxime Meylan, Nadine Ben Hamouda, Amos Kirilovsky, et al. (+12)
2343 [GO] 2021―Jul―12 SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants Daniel Martínez-Flores, Jesús Zepeda-Cervantes, Adolfo Cruz-Reséndiz, Sergio Aguirre-Sampieri, Alicia Sampieri, Luis Vaca
2344 [GO] 2021―Jul―12 A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients Florian Bieberich, Rodrigo Vazquez-Lombardi, Alexander Yermanos, Roy A. Ehling, Derek M. Mason, Bastian Wagner, et al. (+6)
2345 [GO] 2021―Jul―09 Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19 Lei Shi, Rong Ding, Tingting Zhang, Wei Wu, Ziyu Wang, Xiuzhi Jia, et al. (+17)
2346 [GO] 2021―Jul―08 Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era Dan Lv, Jing Peng, Rui Long, Xingguang Lin, Renjie Wang, Di Wu, et al. (+4)
2347 [GO] 2021―Jul―08 The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence Mengyuan Zhang, Xiaoyin Bai, Wei Cao, Junyi Ji, Luo Wang, Yang Yang, Hong Yang
2348 [GO] 2021―Jul―08 Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis Lakhveer Singh, Sakshi Bajaj, Manoj Gadewar, Nitin Verma, Mohd Nazam Ansari, Abdulaziz S. Saeedan, et al. (+2)
2349 [GO] 2021―Jul―08 The Spike of SARS-CoV-2: Uniqueness and Applications Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flavia Figueira Aburjaile, Athira Ch, et al. (+7)
2350 [GO] 2021―Jul―07 From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee
2351 [GO] 2021―Jul―07 SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido, Maria Montoya
2352 [GO] 2021―Jul―07 Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1 Jing Yang, Edith A. Perez, Changchun Hou, Pin Zhang, Michelle Van Scoyk, Robert A. Winn, et al. (+2)
2353 [GO] 2021―Jul―07 ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait (‘CoV-MAC-TED’) for Combating SARS-CoV-2-Induced Cell Reprogramming José Hélio Costa, Gunasekaran Mohanapriya, Revuru Bharadwaj, Carlos Noceda, Karine Leitão Lima Thiers, Shahid Aziz, et al. (+10)
2354 [GO] 2021―Jul―05 Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins Youssif M. Ali, Matteo Ferrari, Nicholas J. Lynch, Sadam Yaseen, Thomas Dudler, Sasha Gragerov, et al. (+3)
2355 [GO] 2021―Jul―05 Hypopharyngeal Ulcers in COVID-19: Histopathological and Virological Analyses - A Case Report Andrea Porzionato, Elena Stocco, Aron Emmi, Martina Contran, Veronica Macchi, Silvia Riccetti, et al. (+3)
2356 [GO] 2021―Jul―05 Commentary: Why Haven’t We Found an Effective Treatment for COVID-19? Josef Brzoska, Harald von Eick, Manfred Hündgen
2357 [GO] 2021―Jul―01 AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19 Anastasia Meshcheryakova, Peter Pietschmann, Philip Zimmermann, Igor B. Rogozin, Diana Mechtcheriakova
2358 [GO] 2021―Jul―01 Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient Changchun Lai, Xinglong Liu, Qihong Yan, Hualiang Lv, Lei Zhou, Longbo Hu, et al. (+19)
2359 [GO] 2021―Jul―01 Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, Abdullah Z. Almutairi, Ahmed A. Alrashed, Abdullah AlJuryyan, et al. (+3)
2360 [GO] 2021―Jun―30 Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19 Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, Rabih Halwani, Imad M. Tleyjeh
2361 [GO] 2021―Jun―30 Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis Eva Schrezenmeier, Leon Bergfeld, David Hillus, Joerg-Detlev Lippert, Ulrike Weber, Pinkus Tober-Lau, et al. (+13)
2362 [GO] 2021―Jun―30 Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Samrein B. M. Ahmed, Suad Hannawi, Rifat Hamoudi, Qutayba Hamid, Rabih Halwani
2363 [GO] 2021―Jun―30 Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update Uttpal Anand, Shweta Jakhmola, Omkar Indari, Hem Chandra Jha, Zhe-Sheng Chen, Vijay Tripathi, José M. Pérez de la Lastra
2364 [GO] 2021―Jun―29 Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design Daniel Ellis, Natalie Brunette, Katharine H. D. Crawford, Alexandra C. Walls, Minh N. Pham, Chengbo Chen, et al. (+21)
2365 [GO] 2021―Jun―28 Case Report: Systemic Sclerosis After Covid-19 Infection Serena Fineschi
2366 [GO] 2021―Jun―28 Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients Sarah Musa Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, Habiba Al Safar, Bassam Mahboub, Axel Künstner, et al. (+5)
2367 [GO] 2021―Jun―28 Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir Yi-Hao Chan, Barnaby E. Young, Siew-Wai Fong, Ying Ding, Yun Shan Goh, Rhonda Sin-Ling Chee, et al. (+7)
2368 [GO] 2021―Jun―28 Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning Bruce K. Patterson, Jose Guevara-Coto, Ram Yogendra, Edgar B. Francisco, Emily Long, Amruta Pise, et al. (+4)
2369 [GO] 2021―Jun―28 Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, Francesco Di Pierro
2370 [GO] 2021―Jun―28 Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection Mingxi Li, Jingao Guo, Shuaiyao Lu, Runhong Zhou, Hongyang Shi, Xuanling Shi, et al. (+25)
2371 [GO] 2021―Jun―25 Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism Ying Shao, Jason Saredy, Keman Xu, Yu Sun, Fatma Saaoud, Charles Drummer, et al. (+7)
2372 [GO] 2021―Jun―25 RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses Takahisa Kouwaki, Tasuku Nishimura, Guanming Wang, Hiroyuki Oshiumi
2373 [GO] 2021―Jun―25 Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets Shane Riddell, Sarah Goldie, Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Kim R. Blasdell, et al. (+5)
2374 [GO] 2021―Jun―24 A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm Mohd Rehan, Firoz Ahmed, Saad M. Howladar, Mohammed Y. Refai, Hanadi M. Baeissa, Torki A. Zughaibi, et al. (+2)
2375 [GO] 2021―Jun―23 Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19 Akash Gupta, Hyung J. Chun
2376 [GO] 2021―Jun―23 EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients Thomas Luft, Clemens-Martin Wendtner, Florentina Kosely, Aleksandar Radujkovic, Axel Benner, Felix Korell, et al. (+4)
2377 [GO] 2021―Jun―23 Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk Claudia Strafella, Valerio Caputo, Gisella Guerrera, Andrea Termine, Carlo Fabrizio, Raffaella Cascella, et al. (+8)
2378 [GO] 2021―Jun―23 SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages Ioanna Pantazi, Ahmed A. Al-Qahtani, Fatimah S Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, et al. (+2)
2379 [GO] 2021―Jun―23 Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype Amelia C. Trombetta, Guilherme B. Farias, André M. C. Gomes, Ana Godinho-Santos, Pedro Rosmaninho, Carolina M. Conceição, et al. (+9)
2380 [GO] 2021―Jun―21 Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Hashim Islam, Thomas C. Chamberlain, Alice L. Mui, Jonathan P. Little
2381 [GO] 2021―Jun―21 Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey Leslie Y. T. Leung, Srijit Khan, Patrick Budylowski, Zhijie Li, Sofiya Goroshko, Yanling Liu, et al. (+5)
2382 [GO] 2021―Jun―21 Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Christina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen
2383 [GO] 2021―Jun―18 Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19 Marianna Rowlands, Florencia Segal, Dominik Hartl
2384 [GO] 2021―Jun―18 COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality Radheshyam Maurya, Prince Sebastian, Madhulika Namdeo, Moodu Devender, Arieh Gertler
2385 [GO] 2021―Jun―17 Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2 Diego Fernández-Lázaro, Cesar I. Fernandez-Lazaro, Juan Mielgo-Ayuso, David P. Adams, Juan Luis García Hernández, Jerónimo González-Bernal, Marcela González-Gross
2386 [GO] 2021―Jun―17 Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy Dawit Wolday, Francis M. Ndungu, Gloria P. Gómez-Pérez, Tobias F. Rinke de Wit
2387 [GO] 2021―Jun―17 The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom Jiajing Wu, Li Zhang, Yue Zhang, Haixin Wang, Ruxia Ding, Jianhui Nie, et al. (+8)
2388 [GO] 2021―Jun―16 Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset Tiandan Xiang, Boyun Liang, Yaohui Fang, Sihong Lu, Sumeng Li, Hua Wang, et al. (+13)
2389 [GO] 2021―Jun―16 A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I Yan Liu, Qi-Zhang Liang, Wan Lu, Yong-Le Yang, Ruiai Chen, Yao-Wei Huang, Bin Wang
2390 [GO] 2021―Jun―16 The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients Emanuel Zitt, Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Beatrix Mutschlechner, Hanno Ulmer, et al. (+4)
2391 [GO] 2021―Jun―15 Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses Georgia Bullen, Jacob D. Galson, Gareth Hall, Pedro Villar, Lien Moreels, Line Ledsgaard, et al. (+29)
2392 [GO] 2021―Jun―14 Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients Eliott Lafon, Gabriel Diem, Christina Witting, Viktoria Zaderer, Rosa Maria Bellmann-Weiler, Markus Reindl, et al. (+10)
2393 [GO] 2021―Jun―14 Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients Ikram Omar Osman, Cléa Melenotte, Philippe Brouqui, Matthieu Million, Jean-Christophe Lagier, Philippe Parola, et al. (+6)
2394 [GO] 2021―Jun―14 Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States Shu-Fang Shih, Abram L. Wagner, Nina B. Masters, Lisa A. Prosser, Yihan Lu, Brian J. Zikmund-Fisher
2395 [GO] 2021―Jun―14 sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection Dhanashree Jagtap, Vikrant M. Bhor, Shilpa Bhowmick, Nandini Kasarpalkar, Pooja Sagvekar, Bhalchandra Kulkarni, et al. (+14)
2396 [GO] 2021―Jun―11 Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies Satoshi Gando, Takeshi Wada
2397 [GO] 2021―Jun―11 Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics Krzysztof Laudanski, Hajj Jihane, Brook Antalosky, Danyal Ghani, Uyen Phan, Ruth Hernandez, et al. (+4)
2398 [GO] 2021―Jun―11 How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility Magdalena Anna Massalska, Hans-Jürgen Gober
2399 [GO] 2021―Jun―11 SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology Augusta Ortolan, Mariagrazia Lorenzin, Chiara Cosma, Giacomo Cozzi, Andrea Padoan, Andrea Doria, et al. (+2)
2400 [GO] 2021―Jun―11 Targeting Future Pandemics, a Case for De Novo Purine Synthesis and Basic Research Randall C. Mazzarino
2401 [GO] 2021―Jun―10 Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI Fabian Bohländer, Dennis Riehl, Sabrina Weißmüller, Marcus Gutscher, Jörg Schüttrumpf, Stefanie Faust
2402 [GO] 2021―Jun―10 Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease Siggeir F. Brynjolfsson, Hildur Sigurgrimsdottir, Elin D. Einarsdottir, Gudrun A. Bjornsdottir, Brynja Armannsdottir, Gudrun E. Baldvinsdottir, et al. (+7)
2403 [GO] 2021―Jun―09 SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells Hua Geng, Saravanan Subramanian, Longtao Wu, Heng-Fu Bu, Xiao Wang, Chao Du, et al. (+2)
2404 [GO] 2021―Jun―09 Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients Liwen Wei, Yuqi Shang, Xi Liu, Xinghua Li, Gongqi Chen, Siping Liang, et al. (+5)
2405 [GO] 2021―Jun―09 Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, et al. (+12)
2406 [GO] 2021―Jun―09 Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection Irene Ramos, Carl Goforth, Alessandra Soares-Schanoski, Dawn L. Weir, Emily C. Samuels, Shreshta Phogat, et al. (+22)
2407 [GO] 2021―Jun―07 Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis? Sandra M. Gonzalez, Abu Bakar Siddik, Ruey-Chyi Su
2408 [GO] 2021―Jun―07 PD-L1 Dysregulation in COVID-19 Patients Francesco Sabbatino, Valeria Conti, Gianluigi Franci, Carmine Sellitto, Valentina Manzo, Pasquale Pagliano, et al. (+14)
2409 [GO] 2021―Jun―07 Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression Angelo Zinellu, Arduino A. Mangoni
2410 [GO] 2021―Jun―04 SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage Yongjun Sui, Jianping Li, David J. Venzon, Jay A. Berzofsky
2411 [GO] 2021―Jun―04 Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern Ashlesha Deshpande, Bethany D. Harris, Luis Martinez-Sobrido, James J. Kobie, Mark R. Walter
2412 [GO] 2021―Jun―03 Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients Zhenyan Wang, Jun Chen, Cuiyun Zhu, Li Liu, Tangkai Qi, Yinzhong Shen, et al. (+6)
2413 [GO] 2021―Jun―03 Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy Ann-Christin Tallarek, Christopher Urbschat, Luis Fonseca Brito, Stephanie Stanelle-Bertram, Susanne Krasemann, Giada Frascaroli, et al. (+11)
2414 [GO] 2021―Jun―02 Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients Marcela Valverde-Monge, José A. Cañas, Blanca Barroso, Diana Betancor, Laura Ortega-Martin, Alicia Gómez-López, et al. (+4)
2415 [GO] 2021―Jun―02 Immunothrombosis in Acute Respiratory Dysfunction of COVID-19 Xiang-Zhi Fang, Ya-Xin Wang, Ji-Qain Xu, Ya-Jun He, Zhe-Kang Peng, You Shang
2416 [GO] 2021―Jun―02 Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients Andrzej Lange, Janusz Lange, Emilia Jaskuła
2417 [GO] 2021―Jun―02 Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets Jon Hazeldine, Janet M. Lord
2418 [GO] 2021―Jun―02 Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells Yanli Li, Enric Mateu
2419 [GO] 2021―Jun―01 Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report Juan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Clara Palmada, Adolf Ruiz-Sanmartin, Marina García-de-Acilu, Erika Plata-Menchaca, et al. (+5)
2420 [GO] 2021―May―28 Potent and Persistent Antibody Response in COVID-19 Recovered Patients Xiaodong Tian, Ling Liu, Wenguo Jiang, He Zhang, Wenjun Liu, Jing Li
2421 [GO] 2021―May―28 Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses Yingying Cao, Xintian Xu, Simo Kitanovski, Lina Song, Jun Wang, Pei Hao, Daniel Hoffmann
2422 [GO] 2021―May―28 Prospects of Neutralizing Nanobodies Against SARS-CoV-2 Fangfang Chen, Zhihong Liu, Fan Jiang
2423 [GO] 2021―May―28 Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity Alexander A. Lehmann, Greg A. Kirchenbaum, Ting Zhang, Pedro A. Reche, Paul V. Lehmann
2424 [GO] 2021―May―26 Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity Lorena Vigón, Daniel Fuertes, Javier García-Pérez, Montserrat Torres, Sara Rodríguez-Mora, Elena Mateos, et al. (+11)
2425 [GO] 2021―May―26 Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features Patricia Zadorosnei Rebutini, Aline Cristina Zanchettin, Emanuele Therezinha Schueda Stonoga, Daniele Margarita Marani Prá, André Luiz Parmegiani de Oliveira, Felipe da Silva Dezidério, et al. (+14)
2426 [GO] 2021―May―26 Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection Marc A. Niles, Patricia Gogesch, Stefanie Kronhart, Samira Ortega Iannazzo, Georg Kochs, Zoe Waibler, Martina Anzaghe
2427 [GO] 2021―May―25 A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19 Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, Karen Donceras Nadua, Danielle E. Anderson, Amanda Jin Mei Lim, et al. (+27)
2428 [GO] 2021―May―24 Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19 Vanessa Chilunda, Pablo Martinez-Aguado, Li C. Xia, Laura Cheney, Aniella Murphy, Veronica Veksler, et al. (+3)
2429 [GO] 2021―May―24 Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, et al. (+6)
2430 [GO] 2021―May―21 COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says Gang Chen, Xiaolin Li, Meixing Sun, Yangzhong Zhou, Meifang Yin, Bin Zhao, Xuemei Li
2431 [GO] 2021―May―20 Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay Isabel Brand, Leonard Gilberg, Jan Bruger, Mercè Garí, Andreas Wieser, Tabea M. Eser, et al. (+16)
2432 [GO] 2021―May―19 Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19? Giovanni A. Rossi, Oliviero Sacco, Antonino Capizzi, Paola Mastromarino
2433 [GO] 2021―May―18 SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1 Liyan Sui, Yinghua Zhao, Wenfang Wang, Ping Wu, Zedong Wang, Yang Yu, et al. (+3)
2434 [GO] 2021―May―18 Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003 Wen-Pin Tseng, Jhong-Lin Wu, Chen-Chi Wu, Kuan-Ting Kuo, Chien-Hao Lin, Ming-Yi Chung, et al. (+7)
2435 [GO] 2021―May―14 Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients Esther J. Nossent, Alex R. Schuurman, Tom D.Y. Reijnders, Anno Saris, Ilse Jongerius, Siebe G. Blok, et al. (+8)
2436 [GO] 2021―May―14 Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles Miao-Hsi Hsieh, Nazar Beirag, Valarmathy Murugaiah, Yu-Chi Chou, Wen-Shuo Kuo, Hui-Fang Kao, et al. (+3)
2437 [GO] 2021―May―13 Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19 Hassan A. Alhazmi, Asim Najmi, Sadique A. Javed, Shahnaz Sultana, Mohammed Al Bratty, Hafiz A. Makeen, et al. (+5)
2438 [GO] 2021―May―13 The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19? Xiaofang Wang, Panpan Yi, Yuejin Liang
2439 [GO] 2021―May―13 Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019 Freimut D. Juengling, Antonio Maldonado, Frank Wuest, Thomas H. Schindler
2440 [GO] 2021―May―13 Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, et al. (+23)
2441 [GO] 2021―May―12 Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, Felipe Barreto Schuch, Ana Paula Duarte de Souza
2442 [GO] 2021―May―11 Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure Pedro Rosa-Guerrero, Antonio Trujillo-Aguilera, Juan Molina, Ana Navas, Cristina López-Martín, Aurora Jurado, et al. (+2)
2443 [GO] 2021―May―11 Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2 Pankaj Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis K. Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra Kolhe
2444 [GO] 2021―May―10 SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms Shahrzad Shoraka, Maria Lucia Brito Ferreira, Seyed Reza Mohebbi, Amir Ghaemi
2445 [GO] 2021―May―10 Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial Harri Hemilä, Anitra Carr, Elizabeth Chalker
2446 [GO] 2021―May―10 The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome Anna Kosyreva, Dzhuliia Dzhalilova, Anastasia Lokhonina, Polina Vishnyakova, Timur Fatkhudinov
2447 [GO] 2021―May―07 Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health Liam Townsend, Adam H. Dyer, Aifric Naughton, Rachel Kiersey, Dean Holden, Mary Gardiner, et al. (+12)
2448 [GO] 2021―May―07 Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression Runzhen Zhao, Zhenlei Su, Andrey A. Komissarov, Shan-Lu Liu, Guohua Yi, Steven Idell, et al. (+2)
2449 [GO] 2021―May―07 Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality Zena Wehbe, Safaa Hisham Hammoud, Hadi M. Yassine, Manal Fardoun, Ahmed F. El-Yazbi, Ali H. Eid
2450 [GO] 2021―May―06 Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling Esra’a Keewan, Shazia Beg, Saleh A. Naser
2451 [GO] 2021―May―05 Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis Ayat Zawawi, Abdallah Y. Naser, Hassan Alwafi, Faisal Minsahwi
2452 [GO] 2021―May―03 Immune Response to COVID-19 During Pregnancy Ge Chen, Qiuyue Liao, Jihui Ai, Bin Yang, Hualin Bai, Jing Chen, et al. (+4)
2453 [GO] 2021―May―03 Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients Esperanza Martín-Sánchez, Juan José Garcés, Catarina Maia, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Carmona-Torre, et al. (+21)
2454 [GO] 2021―May―03 False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases Nastya Kharlamova, Nicky Dunn, Sahl K. Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, et al. (+11)
2455 [GO] 2021―May―03 CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein Pavla Taborska, Zuzana Strizova, Dmitry Stakheev, Ludek Sojka, Jirina Bartunkova, Daniel Smrz
2456 [GO] 2021―May―03 Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure Verena Keitel, Johannes Georg Bode, Torsten Feldt, Andreas Walker, Lisa Müller, Anselm Kunstein, et al. (+21)
2457 [GO] 2021―Apr―30 Cellular Immune Response to COVID-19 and Potential Immune Modulators Xi Zhou, Qing Ye
2458 [GO] 2021―Apr―29 Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease Nicholas R. Medjeral-Thomas, Anne Troldborg, Annette G. Hansen, Jack Gisby, Candice L. Clarke, Maria Prendecki, et al. (+9)
2459 [GO] 2021―Apr―29 Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation Emanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Alessandro Tomelleri, et al. (+10)
2460 [GO] 2021―Apr―29 Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment Juliana Lott Carvalho, Amandda Evelin Silva-Carvalho, Emãnuella Melgaço Garcez, Felipe Saldanha-Araujo
2461 [GO] 2021―Apr―29 NSP2 Is Important for Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus to Trigger High Fever-Related COX-2-PGE2 Pathway in Pigs Li Du, Honglei Wang, Fang Liu, Zeyu Wei, Changjiang Weng, Jun Tang, Wen-hai Feng
2462 [GO] 2021―Apr―28 Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration Ruirong Chen, Zhien Lan, Jujian Ye, Limin Pang, Yi Liu, Wei Wu, et al. (+3)
2463 [GO] 2021―Apr―28 High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, et al. (+15)
2464 [GO] 2021―Apr―28 SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses Katja G. Schmidt, Krystelle Nganou-Makamdop, Matthias Tenbusch, Boutaina El Kenz, Clara Maier, Dennis Lapuente, et al. (+5)
2465 [GO] 2021―Apr―28 SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs Qun Xiang, Zeqing Feng, Bo Diao, Chao Tu, Qinghua Qiao, Han Yang, et al. (+10)
2466 [GO] 2021―Apr―28 A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain Ling Niu, Kathryn N. Wittrock, Gage C. Clabaugh, Vikram Srivastava, Michael W. Cho
2467 [GO] 2021―Apr―26 Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One! Francesca Coperchini, Luca Chiovato, Mario Rotondi
2468 [GO] 2021―Apr―26 Neurological Symptoms of COVID-19: The Zonulin Hypothesis Sílvia Llorens, Eduardo Nava, Mónica Muñoz-López, Álvaro Sánchez-Larsen, Tomás Segura
2469 [GO] 2021―Apr―26 Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222) Gustavo C. Román, Fernando Gracia, Antonio Torres, Alexis Palacios, Karla Gracia, Diógenes Harris
2470 [GO] 2021―Apr―22 Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective Yury O. Nunez Lopez, Anna Casu, Richard E. Pratley
2471 [GO] 2021―Apr―22 Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design Timothy P. Riley, Hui-Ting Chou, Ruozhen Hu, Krzysztof P. Bzymek, Ana R. Correia, Alexander C. Partin, et al. (+6)
2472 [GO] 2021―Apr―22 HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure Seik-Soon Khor, Yosuke Omae, Nao Nishida, Masaya Sugiyama, Noriko Kinoshita, Tetsuya Suzuki, et al. (+7)
2473 [GO] 2021―Apr―22 Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients Esmaeil Mortaz, Payam Tabarsi, Hamidreza Jamaati, Neda Dalil Roofchayee, Neda K. Dezfuli, Seyed MohammadReza Hashemian, et al. (+7)
2474 [GO] 2021―Apr―21 Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1) José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Tatiana Sofía Rodríguez-Reyna, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, et al. (+34)
2475 [GO] 2021―Apr―20 Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 Tanja M. Müller, Emily Becker, Maximilian Wiendl, Lisa Lou Schulze, Caroline Voskens, Simon Völkl, et al. (+3)
2476 [GO] 2021―Apr―19 Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China Wei Cao, Xiaosheng Liu, Ke Hong, Zhiyong Ma, Yuelun Zhang, Ling Lin, et al. (+5)
2477 [GO] 2021―Apr―16 Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus Yufeng Shang, Tao Liu, Jingfeng Li, Natasha Mupeta Kaweme, Xinghuan Wang, Fuling Zhou
2478 [GO] 2021―Apr―16 Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab Jo Linda Sinagra, Claudio Vedovelli, Raffaella Binazzi, Adele Salemme, Francesco Moro, Cinzia Mazzanti, et al. (+2)
2479 [GO] 2021―Apr―15 How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group Francesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, Stefania Carmagnola, Emilio Clementi, Piergiorgio Danelli, et al. (+21)
2480 [GO] 2021―Apr―15 Antibody Responses in COVID-19: A Review Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo J. Patiño, Paula A. Velilla, Maria T. Rugeles
2481 [GO] 2021―Apr―15 SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights Qiao Zhou, Jayakumar Vadakekolathu, Abdulla Watad, Kassem Sharif, Tobias Russell, Hannah Rowe, et al. (+13)
2482 [GO] 2021―Apr―14 Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019 Furong Qi, Wenbo Zhang, Jialu Huang, Lili Fu, Jinfang Zhao
2483 [GO] 2021―Apr―14 Corrigendum: Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen
2484 [GO] 2021―Apr―14 SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia Ritu Mishra, Akhil C. Banerjea
2485 [GO] 2021―Apr―13 Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
2486 [GO] 2021―Apr―12 Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19 Jintao Zhang, Chunyuan Zhao, Wei Zhao
2487 [GO] 2021―Apr―12 COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations Qian He, Qunying Mao, Jialu Zhang, Lianlian Bian, Fan Gao, Junzhi Wang, et al. (+2)
2488 [GO] 2021―Apr―12 Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2 Kathrin Becker, Georg Beythien, Nicole de Buhr, Stephanie Stanelle-Bertram, Berfin Tuku, Nancy Mounogou Kouassi, et al. (+6)
2489 [GO] 2021―Apr―09 Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection Rachel R. Yuen, Dylan Steiner, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Erika L. Smith, et al. (+17)
2490 [GO] 2021―Apr―07 Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19 Nicholas Stoy
2491 [GO] 2021―Apr―07 Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome Steffen Dickel, Clemens Grimm, Katharina Amschler, Sebastian Uwe Schnitzler, Julie Schanz, Onnen Moerer, et al. (+3)
2492 [GO] 2021―Apr―07 Breastfeeding and COVID-19: From Nutrition to Immunity Emilia Vassilopoulou, Gavriela Feketea, Lemonica Koumbi, Christina Mesiari, Elena Camelia Berghea, George N. Konstantinou
2493 [GO] 2021―Apr―01 Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19 Harri Hemilä, Elizabeth Chalker
2494 [GO] 2021―Apr―01 Genetics Insight for COVID-19 Susceptibility and Severity: A Review Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
2495 [GO] 2021―Mar―31 Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19 Marina Luise Viola Azevedo, Aline Cristina Zanchettin, Caroline Busatta Vaz de Paula, Jarbas da Silva Motta Júnior, Mineia Alessandra Scaranello Malaquias, Sonia Mara Raboni, et al. (+10)
2496 [GO] 2021―Mar―31 Why Haven’t We Found an Effective Treatment for COVID-19? Alexander James Spicer, Sirpa Jalkanen
2497 [GO] 2021―Mar―30 Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity Patricia Lamadrid, Marta Alonso-Peña, David San Segundo, Mayte Arias-Loste, Javier Crespo, Marcos Lopez-Hoyos
2498 [GO] 2021―Mar―30 Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities Zena Wehbe, Maya Wehbe, Rabah Iratni, Gianfranco Pintus, Hassan Zaraket, Hadi M. Yassine, Ali H. Eid
2499 [GO] 2021―Mar―29 Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19 Nobunao Ikewaki, Vidyasagar Devaprasad Dedeepiya, Masaru Iwasaki, Samuel J. K. Abraham
2500 [GO] 2021―Mar―29 Age-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19 Nick P. Goplen, In Su Cheon, Jie Sun
2501 [GO] 2021―Mar―29 Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity Anna Schöllhorn, Juliane Schuhmacher, Luciana Besedovsky, Rolf Fendel, Anja T. R. Jensen, Stefan Stevanović, et al. (+5)
2502 [GO] 2021―Mar―29 How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era Jonathan Caron, Laura Alice Ridgley, Mark Bodman-Smith
2503 [GO] 2021―Mar―26 Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, Naseem Ahmed Khan, Adarsh Kumar Chiranjivi, Shailendra Mani, et al. (+7)
2504 [GO] 2021―Mar―26 Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2 Diana Garcia-del-Barco, Daniela Risco-Acevedo, Jorge Berlanga-Acosta, Frank Daniel Martos-Benítez, Gerardo Guillén-Nieto
2505 [GO] 2021―Mar―25 Neutrophils in COVID-19 Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Kevin Baßler, Joachim L. Schultze, Anna C. Aschenbrenner
2506 [GO] 2021―Mar―25 Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection György Sinkovits, Blanka Mező, Marienn Réti, Veronika Müller, Zsolt Iványi, János Gál, et al. (+16)
2507 [GO] 2021―Mar―25 Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children Lesley R. de Armas, Varghese George, Abdelali Filali-Mouhim, Courtney Steel, Anita Parmigiani, Coleen K. Cunningham, et al. (+5)
2508 [GO] 2021―Mar―24 COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire Nabila Seddiki, Martyn French
2509 [GO] 2021―Mar―24 Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins Masahiro Nishibori, Barbara S. Stonestreet
2510 [GO] 2021―Mar―23 Bovine Coronavirus Immune Milk Against COVID-19 Antonio Arenas, Carmen Borge, Alfonso Carbonero, Ignacio Garcia-Bocanegra, David Cano-Terriza, Javier Caballero, Antonio Arenas-Montes
2511 [GO] 2021―Mar―23 SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients Tatjana Schwarz, Kirsten Heiss, Yuvaraj Mahendran, Fiordiligie Casilag, Florian Kurth, Leif E. Sander, et al. (+7)
2512 [GO] 2021―Mar―23 COVID-19-A Theory of Autoimmunity Against ACE-2 Explained Philip McMillan, Thomas Dexhiemer, Richard R. Neubig, Bruce D. Uhal
2513 [GO] 2021―Mar―22 A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2 Xiaojian Han, Yingming Wang, Shenglong Li, Chao Hu, Tingting Li, Chenjian Gu, et al. (+31)
2514 [GO] 2021―Mar―19 Immunity to SARS-CoV-2: Lessons Learned Jaime Fergie, Amit Srivastava
2515 [GO] 2021―Mar―18 Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic Olufunto A. Olusanya, Robert A. Bednarczyk, Robert L. Davis, Arash Shaban-Nejad
2516 [GO] 2021―Mar―18 Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients Massimo Caracciolo, Pierpaolo Correale, Carmelo Mangano, Giuseppe Foti, Carmela Falcone, Sebastiano Macheda, et al. (+14)
2517 [GO] 2021―Mar―17 The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study Ana Copaescu, Fiona James, Effie Mouhtouris, Sara Vogrin, Olivia C. Smibert, Claire L. Gordon, et al. (+3)
2518 [GO] 2021―Mar―16 Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues Karthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, Michael Bachmann, Barbara Seliger
2519 [GO] 2021―Mar―15 Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China Xia Feng, Jiming Yin, Jiaying Zhang, Yaling Hu, Yabo Ouyang, Shubin Qiao, et al. (+8)
2520 [GO] 2021―Mar―12 Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development Marc Baay, Pieter Neels
2521 [GO] 2021―Mar―12 Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review Kuo-Tung Tang, Bo-Chueh Hsu, Der-Yuan Chen
2522 [GO] 2021―Mar―12 Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results Andrea Lombardi, Giorgio Bozzi, Riccardo Ungaro, Simone Villa, Valeria Castelli, Davide Mangioni, et al. (+3)
2523 [GO] 2021―Mar―11 T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19 Olatz Zenarruzabeitia, Gabirel Astarloa-Pando, Iñigo Terrén, Ane Orrantia, Raquel Pérez-Garay, Iratxe Seijas-Betolaza, et al. (+5)
2524 [GO] 2021―Mar―11 Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection Asgar Ansari, Rakesh Arya, Shilpa Sachan, Someshwar Nath Jha, Anurag Kalia, Anupam Lall, et al. (+6)
2525 [GO] 2021―Mar―11 Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment Miguel Angel Martinez
2526 [GO] 2021―Mar―11 Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Ge Li, Aiping Wang, Yumei Chen, Yaning Sun, Yongkun Du, Xun Wang, et al. (+4)
2527 [GO] 2021―Mar―11 Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen Vikram Srivastava, Ling Niu, Kruttika S. Phadke, Bryan H. Bellaire, Michael W. Cho
2528 [GO] 2021―Mar―10 Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody Simon Gebremeskel, Julia Schanin, Krysta M. Coyle, Melina Butuci, Thuy Luu, Emily C. Brock, et al. (+8)
2529 [GO] 2021―Mar―09 The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic Priyanka Shah, Gabriela A. Canziani, Erik P. Carter, Irwin Chaiken
2530 [GO] 2021―Mar―09 Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients Marco Contoli, Alberto Papi, Luca Tomassetti, Paola Rizzo, Francesco Vieceli Dalla Sega, Francesca Fortini, et al. (+11)
2531 [GO] 2021―Mar―09 The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus Andrew R. Kick, Amanda F. Amaral, Alba Frias-De-Diego, Lizette M. Cortes, Jonathan E. Fogle, Elisa Crisci, et al. (+2)
2532 [GO] 2021―Mar―08 Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C) Gavriela Feketea, Vasiliki Vlacha, Ioana Corina Bocsan, Emilia Vassilopoulou, Luminita Aurelia Stanciu, Mihnea Zdrenghea
2533 [GO] 2021―Mar―08 The BCG Vaccine for COVID-19: First Verdict and Future Directions Maria Gonzalez-Perez, Rodrigo Sanchez-Tarjuelo, Boris Shor, Estanislao Nistal-Villan, Jordi Ochando
2534 [GO] 2021―Mar―08 Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification Vince Kornél Grolmusz, Anikó Bozsik, János Papp, Attila Patócs
2535 [GO] 2021―Mar―04 The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients Huanle Luo, Tingting Jia, Jiamin Chen, Shike Zeng, Zengzhao Qiu, Shu Wu, et al. (+14)
2536 [GO] 2021―Mar―04 Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment Jian Wu, Jiawei Shen, Ying Han, Qinghua Qiao, Wei Dai, Bangshun He, et al. (+12)
2537 [GO] 2021―Mar―03 Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19 Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, Thomas Kirschning
2538 [GO] 2021―Mar―01 SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients Marton Olbei, Isabelle Hautefort, Dezso Modos, Agatha Treveil, Martina Poletti, Lejla Gul, et al. (+2)
2539 [GO] 2021―Feb―26 A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation Hyein Jeong, Yu-Min Choi, Hyejun Seo, Bum-Joon Kim
2540 [GO] 2021―Feb―26 A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic Chris R. Triggle, Devendra Bansal, Hong Ding, Md Mazharul Islam, Elmoubashar Abu Baker Abd Farag, Hamad Abdel Hadi, Ali A. Sultan
2541 [GO] 2021―Feb―26 COVID-19 Impairs Immune Response to Candida albicans Dominique Moser, Katharina Biere, Bing Han, Marion Hoerl, Gustav Schelling, Alexander Choukér, Tobias Woehrle
2542 [GO] 2021―Feb―26 Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia Maria Antonella Zingaropoli, Parni Nijhawan, Anna Carraro, Patrizia Pasculli, Paola Zuccalà, Valentina Perri, et al. (+10)
2543 [GO] 2021―Feb―26 Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children Men-Ren Chen, Ho-Chang Kuo, Yann-Jinn Lee, Hsin Chi, Sung Chou Li, Hung-Chang Lee, Kuender D. Yang
2544 [GO] 2021―Feb―26 CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, et al. (+23)
2545 [GO] 2021―Feb―25 In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection Juliana de Melo Batista dos Santos, Camila Pereira Soares, Fernanda Rodrigues Monteiro, Ralyria Mello, Jonatas Bussador do Amaral, Andressa Simões Aguiar, et al. (+14)
2546 [GO] 2021―Feb―24 Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies Darrell O. Ricke
2547 [GO] 2021―Feb―24 Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19 Maria G. Balta, Evangelos Papathanasiou, Panagiotis F. Christopoulos
2548 [GO] 2021―Feb―24 Microbiota Modulation of the Gut-Lung Axis in COVID-19 Gislane Lelis Vilela de Oliveira, Camilla Narjara Simão Oliveira, Camila Figueiredo Pinzan, Larissa Vedovato Vilela de Salis, Cristina Ribeiro de Barros Cardoso
2549 [GO] 2021―Feb―24 Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients Shun Li, Bin Wu, Yun Ling, Mingquan Guo, Boyin Qin, Xiaonan Ren, et al. (+19)
2550 [GO] 2021―Feb―23 Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19 Maxim Shkurnikov, Stepan Nersisyan, Tatjana Jankevic, Alexei Galatenko, Ivan Gordeev, Valery Vechorko, Alexander Tonevitsky
2551 [GO] 2021―Feb―22 Glycocalyx as Possible Limiting Factor in COVID-19 Patricia P. Wadowski, Bernd Jilma, Christoph W. Kopp, Sebastian Ertl, Thomas Gremmel, Renate Koppensteiner
2552 [GO] 2021―Feb―22 Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients Sergej Tomić, Jelena Đokić, Dejan Stevanović, Nataša Ilić, Alisa Gruden-Movsesijan, Miroslav Dinić, et al. (+7)
2553 [GO] 2021―Feb―22 The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System Miklós Lipcsey, Barbro Persson, Oskar Eriksson, Anna M. Blom, Karin Fromell, Michael Hultström, et al. (+4)
2554 [GO] 2021―Feb―22 Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-β Production via Blocking the Interaction Between TRAF3 and TBK1 Zhihai Zhou, Yuan Sun, Jingya Xu, Xiaoyu Tang, Ling Zhou, Qianniu Li, et al. (+2)
2555 [GO] 2021―Feb―22 Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows Jordan E. Young, Cheryl M. T. Dvorak, Simon P. Graham, Michael P. Murtaugh
2556 [GO] 2021―Feb―20 Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19 Qiong Zhang, Yuting Meng, Kaihang Wang, Xujun Zhang, Wenbiao Chen, Jifang Sheng, et al. (+3)
2557 [GO] 2021―Feb―20 Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective? Allan Kalungi, Eugene Kinyanda, Dickens Howard Akena, Pontiano Kaleebu, Innocent M. Bisangwa
2558 [GO] 2021―Feb―20 Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia André Santa Cruz, Ana Mendes-Frias, Ana Isabel Oliveira, Luís Dias, Ana Rita Matos, Alexandre Carvalho, et al. (+4)
2559 [GO] 2021―Feb―20 High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China Wei Cao, Xiaosheng Liu, Ke Hong, Zhiyong Ma, Yuelun Zhang, Ling Lin, et al. (+5)
2560 [GO] 2021―Feb―18 Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study Jing Zhang, Zhihua Wang, Xiong Wang, Zhiquan Hu, Chunguang Yang, Ping Lei
2561 [GO] 2021―Feb―18 The Promise of Aggregation-Induced Emission Luminogens for Detecting COVID-19 Zongwei Liu, Ting Meng, Xiaofang Tang, Ran Tian, Weijiang Guan
2562 [GO] 2021―Feb―17 Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications Marinos C. Dalakas, Kleopatra Bitzogli, Harry Alexopoulos
2563 [GO] 2021―Feb―13 Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19 Vincent J. Venditto, Dalia Haydar, Ahmed Abdel-Latif, John C. Gensel, Michael I. Anstead, Michelle G. Pitts, et al. (+4)
2564 [GO] 2021―Feb―13 The Immunopathology of COVID-19 and the Cannabis Paradigm Nicole Paland, Antonina Pechkovsky, Miran Aswad, Haya Hamza, Tania Popov, Eduardo Shahar, Igal Louria-Hayon
2565 [GO] 2021―Feb―08 Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19 Zhen Qin, Kefa Xiang, Ding-Feng Su, Yang Sun, Xia Liu
2566 [GO] 2021―Feb―05 The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences Tayrine Ordonio Filgueira, Angela Castoldi, Lucas Eduardo R. Santos, Geraldo José de Amorim, Matheus Santos de Sousa Fernandes, Weydyson de Lima do Nascimento Anastácio, et al. (+3)
2567 [GO] 2021―Feb―05 Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects Ching-Hsuan Liu, Cheng-Hua Lu, Shu Hui Wong, Liang-Tzung Lin
2568 [GO] 2021―Feb―04 Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition K. de Joode, A. A. M. Oostvogels, C. H. GeurtsvanKessel, R. D. de Vries, R. H. J. Mathijssen, R. Debets, A. A. M. van der Veldt
2569 [GO] 2021―Feb―03 Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19 Charles Ochieng’ Olwal, Nora Nghuchuzie Nganyewo, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Oloche Owoicho, Yaw Bediako, Samuel Duodu
2570 [GO] 2021―Feb―03 An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19? Sijia Zhao, Ting Xie, Li Shen, Hong Liu, Liling Wang, Xixiang Ma, et al. (+4)
2571 [GO] 2021―Feb―02 Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients Ling Ni, Meng-Li Cheng, Yu Feng, Hui Zhao, Jingyuan Liu, Fang Ye, et al. (+13)
2572 [GO] 2021―Jan―29 Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19 Xianfang Tang, Lijun Cai, Yajie Meng, JunLin Xu, Changcheng Lu, Jialiang Yang
2573 [GO] 2021―Jan―29 Complement Activation in Kidneys of Patients With COVID-19 Frederick Pfister, Eva Vonbrunn, Tajana Ries, Hans-Martin Jäck, Klaus Überla, Günter Lochnit, et al. (+5)
2574 [GO] 2021―Jan―29 High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19 Aiping Ma, Liang Zhang, Xiaokai Ye, Jing Chen, Jie Yu, Liangjin Zhuang, et al. (+4)
2575 [GO] 2021―Jan―29 COVID-19: Imbalanced Immune Responses and Potential Immunotherapies Bing Xie, Jiancheng Zhang, Yuwen Li, Shiying Yuan, You Shang
2576 [GO] 2021―Jan―29 COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes Thais Fernanda de Campos Fraga-Silva, Sandra Regina Maruyama, Carlos Arterio Sorgi, Elisa Maria de Sousa Russo, Ana Paula Morais Fernandes, Cristina Ribeiro de Barros Cardoso, et al. (+3)
2577 [GO] 2021―Jan―29 Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Benito Minjarez, Ulises Gómez-Pinedo, Ana Laura Márquez-Aguirre, Juan Carlos Mateos-Díaz, et al. (+2)
2578 [GO] 2021―Jan―29 Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses Stephan Schlickeiser, Tatjana Schwarz, Sophie Steiner, Kirsten Wittke, Nabeel Al Besher, Oliver Meyer, et al. (+12)
2579 [GO] 2021―Jan―28 Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, Shiwei Xu, Joshua A. Weiner, Carly A. Bobak, et al. (+6)
2580 [GO] 2021―Jan―28 Key Components of Inflammasome and Pyroptosis Pathways Are Deficient in Canines and Felines, Possibly Affecting Their Response to SARS-CoV-2 Infection Haoran Cui, Leiliang Zhang
2581 [GO] 2021―Jan―28 Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model Tingxuan Gu, Simin Zhao, Guoguo Jin, Mengqiu Song, Yafei Zhi, Ran Zhao, et al. (+10)
2582 [GO] 2021―Jan―26 COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases Katja Lakota, Katja Perdan-Pirkmajer, Alojzija Hočevar, Snezna Sodin-Semrl, Žiga Rotar, Saša Čučnik, Polona Žigon
2583 [GO] 2021―Jan―26 Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature Wilma Barcellini, Juri Alessandro Giannotta, Bruno Fattizzo
2584 [GO] 2021―Jan―26 Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice Eva Fisher, Laura Padula, Kristin Podack, Katelyn O’Neill, Matthew M. Seavey, Padmini Jayaraman, et al. (+2)
2585 [GO] 2021―Jan―25 Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm? Ramachandran Vignesh, Chinnambedu Ravichandran Swathirajan, Zaw Htet Tun, Marimuthu Ragavan Rameshkumar, Sunil Suhas Solomon, Pachamuthu Balakrishnan
2586 [GO] 2021―Jan―22 Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides? Rebeca Garcia-Fandino, Ángel Piñeiro
2587 [GO] 2021―Jan―22 Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus Geoffrey P. Dobson, Erik Biros, Hayley L. Letson, Jodie L. Morris
2588 [GO] 2021―Jan―20 Corrigendum: Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients Xuefeng Niu, Song Li, Pingchao Li, Wenjing Pan, Qian Wang, Ying Feng, et al. (+15)
2589 [GO] 2021―Jan―20 Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences Jianfen Meng, Yuning Ma, Jinchao Jia, Mengyan Wang, Jialin Teng, Hui Shi, et al. (+18)
2590 [GO] 2021―Jan―19 Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases Aristo Vojdani, Elroy Vojdani, Datis Kharrazian
2591 [GO] 2021―Jan―14 Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel Nufar Marcus, Shirly Frizinsky, David Hagin, Adi Ovadia, Suhair Hanna, Michael Farkash, et al. (+17)
2592 [GO] 2021―Jan―14 Does Angiotensin II Peak in Response to SARS-CoV-2? Léder Leal Xavier, Paula Fernanda Ribas Neves, Lisiê Valeria Paz, Laura Tartari Neves, Pamela Brambilla Bagatini, Luís Fernando Saraiva Macedo Timmers, et al. (+3)
2593 [GO] 2021―Jan―14 Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2? Anastasia Polycarpou, Sofia Grigoriadou, Linda Klavinskis, Steven Sacks
2594 [GO] 2021―Jan―10 Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations Julien Carvelli, Audrey Le Saux, Jeremy Bourenne, Marc Gainnier, Gilles Kaplanski
2595 [GO] 2021―Jan―10 Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures Jacob D. Galson, Sebastian Schaetzle, Rachael J. M. Bashford-Rogers, Matthew I. J. Raybould, Aleksandr Kovaltsuk, Gavin J. Kilpatrick, et al. (+15)
2596 [GO] 2021―Jan―10 Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases Rita Carsetti, Salvatore Zaffina, Eva Piano Mortari, Sara Terreri, Francesco Corrente, Claudia Capponi, et al. (+24)
2597 [GO] 2021―Jan―08 Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19 Rachel S. Cooper, Alasdair R. Fraser, Linda Smith, Paul Burgoyne, Stuart N. Imlach, Lisa M. Jarvis, et al. (+4)
2598 [GO] 2021―Jan―08 HLA, Immune Response, and Susceptibility to COVID-19 Fataneh Tavasolian, Mohsen Rashidi, Gholam Reza Hatam, Marjan Jeddi, Ahmad Zavaran Hosseini, Sayed Hussain Mosawi, et al. (+2)
2599 [GO] 2021―Jan―08 Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients Lili Li, Jie Li, Meiling Gao, Huimin Fan, Yanan Wang, Xin Xu, et al. (+11)
2600 [GO] 2021―Jan―08 SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response Jackson S. Turner, Aaron Day, Wafaa B. Alsoussi, Zhuoming Liu, Jane A. O’Halloran, Rachel M. Presti, et al. (+4)
2601 [GO] 2020―Dec―23 The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19 Jing Guo, He Xia, Shuting Wang, Liang Yu, Huafen Zhang, Jun Chen, et al. (+8)
2602 [GO] 2020―Dec―23 COVID-19: Coronavirus Vaccine Development Updates Jing Zhao, Shan Zhao, Junxian Ou, Jing Zhang, Wendong Lan, Wenyi Guan, et al. (+6)
2603 [GO] 2020―Dec―23 HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients Sophie Steiner, Franziska Sotzny, Sandra Bauer, Il-Kang Na, Michael Schmueck-Henneresse, Victor M. Corman, et al. (+7)
2604 [GO] 2020―Dec―23 Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management Matthaios Speletas, Maria A. Kyritsi, Alexandros Vontas, Aikaterini Theodoridou, Theofilos Chrysanthidis, Sophia Hatzianastasiou, et al. (+2)
2605 [GO] 2020―Dec―22 Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity Tugce Karaderi, Halin Bareke, Imge Kunter, Adil Seytanoglu, Ilgin Cagnan, Deniz Balci, et al. (+5)
2606 [GO] 2020―Dec―22 RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics? Jonas B. Sandbrink, Robin J. Shattock
2607 [GO] 2020―Dec―21 Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19 Anthony J. Leonardi, Rui B. Proenca
2608 [GO] 2020―Dec―18 Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19 Marco Antônio M. Pretti, Rômulo G. Galvani, Gustavo Fioravanti Vieira, Adriana Bonomo, Martín H. Bonamino, Mariana Boroni
2609 [GO] 2020―Dec―18 Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System Xiaorong Peng, Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Biao Zhu, Jean-Pierre Routy
2610 [GO] 2020―Dec―18 NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker, Oliver Planz
2611 [GO] 2020―Dec―18 Humoral Responses and Serological Assays in SARS-CoV-2 Infections Yannick Galipeau, Matthew Greig, George Liu, Matt Driedger, Marc-André Langlois
2612 [GO] 2020―Dec―18 A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters Anna C. Fagre, John Manhard, Rachel Adams, Miles Eckley, Shijun Zhan, Juliette Lewis, et al. (+13)
2613 [GO] 2020―Dec―11 SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, Roslye V. Berrios, Linmar Rodríguez-Guilarte, María C. Opazo, et al. (+2)
2614 [GO] 2020―Dec―10 Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension Qiang Zeng, Yong-Zhe Li, Sheng-Yong Dong, Zong-Tao Chen, Xiang-Yang Gao, Han Zhang, et al. (+2)
2615 [GO] 2020―Dec―09 Biomodulina T (InmunyVital®) Restores T Cells and Helps Contain COVID-19 Roman R. Rodriguez Martin, Olivia Gonzalez Gonzalez, Carolina Rodriguez Gonzalez, Rene R. Rodriguez Gonzalez
2616 [GO] 2020―Dec―09 Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes Andrea Lombardi, Elena Trombetta, Alessandra Cattaneo, Valeria Castelli, Emanuele Palomba, Mario Tirone, et al. (+13)
2617 [GO] 2020―Dec―09 A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection Firoz Ahmed
2618 [GO] 2020―Dec―09 Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020) David S. Kim, Sarah Rowland-Jones, Ester Gea-Mallorquí
2619 [GO] 2020―Dec―04 A Potential Bioelectromagnetic Method to Slow Down the Progression and Prevent the Development of Ultimate Pulmonary Fibrosis by COVID-19 Syed Muzzammil Masaud, Oliver Szasz, A. Marcell Szasz, Huma Ejaz, Rana Attique Anwar, Andras Szasz
2620 [GO] 2020―Dec―04 Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience Roberto Littera, Marcello Campagna, Silvia Deidda, Goffredo Angioni, Selene Cipri, Maurizio Melis, et al. (+28)
2621 [GO] 2020―Dec―03 B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients Víctor A. Sosa-Hernández, Jiram Torres-Ruíz, Rodrigo Cervantes-Díaz, Sandra Romero-Ramírez, José C. Páez-Franco, David E. Meza-Sánchez, et al. (+9)
2622 [GO] 2020―Dec―01 Impact of Diabetes in Patients Diagnosed With COVID-19 Mohamed Abu-Farha, Fahd Al-Mulla, Thangavel Alphonse Thanaraj, Sina Kavalakatt, Hamad Ali, Mohammed Abdul Ghani, Jehad Abubaker
2623 [GO] 2020―Dec―01 Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING? Jean-Marie Berthelot, Frédéric Lioté, Yves Maugars, Jean Sibilia
2624 [GO] 2020―Nov―30 Controlling Cytokine Storm Is Vital in COVID-19 Lu Tang, Zhinan Yin, Yu Hu, Heng Mei
2625 [GO] 2020―Nov―30 Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection Michael W. Russell, Zina Moldoveanu, Pearay L. Ogra, Jiri Mestecky
2626 [GO] 2020―Nov―30 Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis Xijie Dong, Chuntao Wang, Xinghua Liu, Wei Gao, Xiangjun Bai, Zhanfei Li
2627 [GO] 2020―Nov―26 Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset Juan Francisco Gutiérrez-Bautista, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, Pilar Jiménez, Federico Garrido, Per Anderson, et al. (+2)
2628 [GO] 2020―Nov―25 Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2 Xia Xiao, Conghui Wang, De Chang, Ying Wang, Xiaojing Dong, Tao Jiao, et al. (+6)
2629 [GO] 2020―Nov―24 Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report Sabina Cenciarelli, Valeria Calbi, Federica Barzaghi, Maria Ester Bernardo, Chiara Oltolini, Maddalena Migliavacca, et al. (+26)
2630 [GO] 2020―Nov―23 Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes? Vaia Lambadiari, Foteini Kousathana, Athanasios Raptis, Konstantinos Katogiannis, Alexander Kokkinos, Ignatios Ikonomidis
2631 [GO] 2020―Nov―20 Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19 Karel F. A. Van Damme, Simon Tavernier, Nele Van Roy, Elisabeth De Leeuw, Jozefien Declercq, Cédric Bosteels, et al. (+14)
2632 [GO] 2020―Nov―19 Analysis of Peripheral Blood IL-6 and Leukocyte Characteristics in 364 COVID-19 Patients of Wuhan Quan Li, Yuyu Xie, Zhangbo Cui, Shi Tang, Baodong Yuan, Hai Huang, et al. (+4)
2633 [GO] 2020―Nov―18 MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity Miguel A. Vega, Miriam Simón-Fuentes, Arturo González de la Aleja, Concha Nieto, María Colmenares, Cristina Herrero, et al. (+2)
2634 [GO] 2020―Nov―13 Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis Li Zhang, Binyang Zheng, Xingsu Gao, Libo Zhang, Hongxin Pan, Yong Qiao, et al. (+2)
2635 [GO] 2020―Nov―09 Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art Yinhua Zhang, Yuanyuan Chen, Zhongji Meng
2636 [GO] 2020―Nov―06 Adjuvants for Coronavirus Vaccines Zhihui Liang, Haoru Zhu, Xin Wang, Bo Jing, Zifan Li, Xinyu Xia, et al. (+6)
2637 [GO] 2020―Nov―05 Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains Chloe H. Lee, Mariana Pereira Pinho, Paul R. Buckley, Isaac B. Woodhouse, Graham Ogg, Alison Simmons, et al. (+2)
2638 [GO] 2020―Nov―02 Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus Isabel Kinney Ferreira De Miranda Santos, Carlos Henrique Nery Costa
2639 [GO] 2020―Oct―30 NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19 Alberto López-Reyes, Carlos Martinez-Armenta, Rocio Espinosa-Velázquez, Paola Vázquez-Cárdenas, Marlid Cruz-Ramos, Berenice Palacios-Gonzalez, et al. (+2)
2640 [GO] 2020―Oct―30 COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics Allison P. Spihlman, Nirupa Gadi, Samantha C. Wu, Vaishali R. Moulton
2641 [GO] 2020―Oct―30 CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization Brien K. Haun, Chih-Yun Lai, Caitlin A. Williams, Teri Ann S. Wong, Michael M. Lieberman, Laurent Pessaint, et al. (+2)
2642 [GO] 2020―Oct―28 The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19 Giuseppe Cerullo, Massimo Negro, Mauro Parimbelli, Michela Pecoraro, Simone Perna, Giorgio Liguori, et al. (+3)
2643 [GO] 2020―Oct―28 I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato
2644 [GO] 2020―Oct―28 Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic Pritom Chowdhury, Anoop Kumar Barooah
2645 [GO] 2020―Oct―28 Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets Sergio C. Oliveira, Mariana T. Q. de Magalhães, E. Jane Homan
2646 [GO] 2020―Oct―27 A 21st Century Evil: Immunopathology and New Therapies of COVID-19 Taylon Felipe Silva, Fernanda Tomiotto-Pellissier, Raquel Arruda Sanfelice, Manoela Daiele Gonçalves, Bruna Taciane da Silva Bortoleti, Mariana Barbosa Detoni, et al. (+8)
2647 [GO] 2020―Oct―27 Corrigendum: Interferon-α2b Treatment for COVID-19 Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, et al. (+4)
2648 [GO] 2020―Oct―23 SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19 Howard M. Johnson, Alfred S. Lewin, Chulbul M. Ahmed
2649 [GO] 2020―Oct―23 A Longitudinal Study of Immune Cells in Severe COVID-19 Patients Didier Payen, Maxime Cravat, Hadil Maadadi, Carole Didelot, Lydia Prosic, Claire Dupuis, et al. (+2)
2650 [GO] 2020―Oct―22 Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology Abhishek Dubey, Surbhi Dahiya, Barry T. Rouse, Sharvan Sehrawat
2651 [GO] 2020―Oct―21 COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions Giovanni Manzo
2652 [GO] 2020―Oct―20 Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness Camilla Tincati, E. Stefania Cannizzo, Mauro Giacomelli, Raffaele Badolato, Antonella d’Arminio Monforte, Giulia Marchetti
2653 [GO] 2020―Oct―16 Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines Pedro A. Reche
2654 [GO] 2020―Oct―15 Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, Daniele Curreli, Germana Cecchini, Caterina Bodio, et al. (+21)
2655 [GO] 2020―Oct―15 Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis? Alberto Beretta, Martin Cranage, Donato Zipeto
2656 [GO] 2020―Oct―14 A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 Omna Sharma, Ali A. Sultan, Hong Ding, Chris R. Triggle
2657 [GO] 2020―Oct―14 Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease Mingyue Li, Weina Guo, Yalan Dong, Xiaobei Wang, Die Dai, Xingxing Liu, et al. (+18)
2658 [GO] 2020―Oct―14 The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation Chanan Meydan, Nimrod Madrer, Hermona Soreq
2659 [GO] 2020―Oct―14 Coronavirus Proteins as Ion Channels: Current and Potential Research Conor McClenaghan, Alex Hanson, Sun-Joo Lee, Colin G. Nichols
2660 [GO] 2020―Oct―12 A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds Lara Schöler, Vu Thuy Khanh Le-Trilling, Mareike Eilbrecht, Denise Mennerich, Olympia E. Anastasiou, Adalbert Krawczyk, et al. (+3)
2661 [GO] 2020―Oct―08 The Inflammasome in Times of COVID-19 Juan Carlos de Rivero Vaccari, W. Dalton Dietrich, Robert W. Keane, Juan Pablo de Rivero Vaccari
2662 [GO] 2020―Oct―08 T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis Bahire Kalfaoglu, José Almeida-Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono
2663 [GO] 2020―Oct―08 COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation Luis Fonte, Armando Acosta, Maria E. Sarmiento, María Ginori, Gissel García, Mohd Nor Norazmi
2664 [GO] 2020―Oct―07 Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19 M. Mrityunjaya, V. Pavithra, R. Neelam, P. Janhavi, P. M. Halami, P. V. Ravindra
2665 [GO] 2020―Oct―07 ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19 Donato Zipeto, Julys da Fonseca Palmeira, Gustavo A. Argañaraz, Enrique R. Argañaraz
2666 [GO] 2020―Oct―07 The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens Liangwei Duan, Qianqian Zheng, Hongxia Zhang, Yuna Niu, Yunwei Lou, Hui Wang
2667 [GO] 2020―Oct―06 Increased Plasma Heparanase Activity in COVID-19 Patients Baranca Buijsers, Cansu Yanginlar, Aline de Nooijer, Inge Grondman, Marissa L. Maciej-Hulme, Inge Jonkman, et al. (+13)
2668 [GO] 2020―Oct―06 Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study Quirin Notz, Marc Schmalzing, Florian Wedekink, Tobias Schlesinger, Michael Gernert, Johannes Herrmann, et al. (+9)
2669 [GO] 2020―Oct―06 Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Jon Hazeldine, Janet M. Lord
2670 [GO] 2020―Oct―06 A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 Ludovico De Stefano, Francesca Bobbio-Pallavicini, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti
2671 [GO] 2020―Oct―06 SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment Khalil Khalaf, Natalia Papp, Jadzia Tin-Tsen Chou, Doris Hana, Andrzej Mackiewicz, Mariusz Kaczmarek
2672 [GO] 2020―Oct―02 Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) Daniel Gagiannis, Julie Steinestel, Carsten Hackenbroch, Benno Schreiner, Michael Hannemann, Wilhelm Bloch, et al. (+6)
2673 [GO] 2020―Oct―02 Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases Martina Ranzenigo, Claudia Pastori, Gabriel Siracusano, Elena Pariani, Caterina Uberti-Foppa, Lucia Lopalco
2674 [GO] 2020―Oct―02 Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine Macartney, et al. (+3)
2675 [GO] 2020―Sep―30 The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19 Gideon Schreiber
2676 [GO] 2020―Sep―30 As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention Craig R. Travis
2677 [GO] 2020―Sep―30 Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients Xuefeng Niu, Song Li, Pingchao Li, Wenjing Pan, Qian Wang, Ying Feng, et al. (+15)
2678 [GO] 2020―Sep―30 Covid-19: Perspectives on Innate Immune Evasion Nima Taefehshokr, Sina Taefehshokr, Nima Hemmat, Bryan Heit
2679 [GO] 2020―Sep―30 Is Herd Immunity Against SARS-CoV-2 a Silver Lining? Ramachandran Vignesh, Esaki M. Shankar, Vijayakumar Velu, Sadras Panchatcharam Thyagarajan
2680 [GO] 2020―Sep―30 Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer Antonio Barbieri, Nirmal Robinson, Giuseppe Palma, Nicola Maurea, Vincenzo Desiderio, Gerardo Botti
2681 [GO] 2020―Sep―29 Targeting Lipid Rafts-A Potential Therapy for COVID-19 Dmitri Sviridov, Yury I. Miller, Rami A. Ballout, Alan T. Remaley, Michael Bukrinsky
2682 [GO] 2020―Sep―29 Immune Correlates of COVID-19 Control Bhawna Poonia, Shyam Kottilil
2683 [GO] 2020―Sep―29 Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients Zhong-Jie Hu, Jia Xu, Ji-Ming Yin, Li Li, Wei Hou, Li-Li Zhang, et al. (+5)
2684 [GO] 2020―Sep―29 Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial Salman Sadullah Usmani, Gajendra P. S. Raghava
2685 [GO] 2020―Sep―28 An Effective COVID-19 Vaccine Needs to Engage T Cells Karsten Sauer, Tim Harris
2686 [GO] 2020―Sep―25 Perspective: The Potential Effects of Naringenin in COVID-19 Ricardo Wesley Alberca, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Milena Mary de Souza Andrade, Anna Julia Pietrobon, Maria Notomi Sato
2687 [GO] 2020―Sep―25 Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS Ludmila Lupu, Annette Palmer, Markus Huber-Lang
2688 [GO] 2020―Sep―24 COVID-19: In the Eye of the Cytokine Storm Roberto de la Rica, Marcio Borges, Marta Gonzalez-Freire
2689 [GO] 2020―Sep―24 Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting - A Hypothesis Z. Shadi Farhangrazi, Giulio Sancini, A. Christy Hunter, Seyed Moein Moghimi
2690 [GO] 2020―Sep―23 Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology Jose Gómez-Rial, Maria José Currás-Tuala, Irene Rivero-Calle, Alberto Gómez-Carballa, Miriam Cebey-López, Carmen Rodríguez-Tenreiro, et al. (+7)
2691 [GO] 2020―Sep―23 Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Jean-Pierre Routy, Yaokai Chen
2692 [GO] 2020―Sep―18 Cell-Free Therapies: Novel Approaches for COVID-19 Tatiana Maron-Gutierrez, Patricia R. M. Rocco
2693 [GO] 2020―Sep―18 Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis Jarbas da Silva Motta Junior, Anna Flavia Ribeiro dos Santos Miggiolaro, Seigo Nagashima, Caroline Busatta Vaz de Paula, Cristina Pellegrino Baena, Julio Scharfstein, Lucia de Noronha
2694 [GO] 2020―Sep―18 Familial Mediterranean Fever and COVID-19: Friends or Foes? Alessandro Stella, Mohamed Lamkanfi, Piero Portincasa
2695 [GO] 2020―Sep―17 Immunopathogenesis of COVID-19: Summary and Possible Interventions Francois Henri Jacques, Erik Apedaile
2696 [GO] 2020―Sep―17 Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen
2697 [GO] 2020―Sep―15 Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort Kyle Kasparian, David Graykowski, Eiron C�ck
2698 [GO] 2020―Sep―11 COVID-19: Infection or Autoimmunity Timothy Icenogle
2699 [GO] 2020―Sep―11 Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses Zeinab Abdelrahman, Mengyuan Li, Xiaosheng Wang
2700 [GO] 2020―Sep―10 Neurological Damage by Coronaviruses: A Catastrophe in the Queue! Ritu Mishra, Akhil C. Banerjea
2701 [GO] 2020―Sep―04 Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19 Wenxin Xu, Mingjie Wang, Demin Yu, Xinxin Zhang
2702 [GO] 2020―Sep―04 Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends” Thomas-Oliver Kleen, Alicia A. Galdon, Andrew S. MacDonald, Angus G. Dalgleish
2703 [GO] 2020―Sep―03 Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country David Requena, Aldhair Médico, Ruy D. Chacón, Manuel Ramírez, Obert Marín-Sánchez
2704 [GO] 2020―Sep―02 Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19 Sen Qun, Yulan Wang, Jun Chen, Xiang Huang, Hui Guo, Zhaohui Lu, et al. (+15)
2705 [GO] 2020―Sep―02 Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease? Geoffrey Mark Verrall
2706 [GO] 2020―Sep―02 Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in” Vanessa Castelli, Annamaria Cimini, Claudio Ferri
2707 [GO] 2020―Aug―28 Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19 Jang Hyun Park, Heung Kyu Lee
2708 [GO] 2020―Aug―28 The Metabolic Changes and Immune Profiles in Patients With COVID-19 Bing He, Jun Wang, Yudie Wang, Juan Zhao, Juan Huang, Yu Tian, et al. (+6)
2709 [GO] 2020―Aug―28 COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis Markus A. Schramm, Nils Venhoff, Dirk Wagner, Jens Thiel, Daniela Huzly, Nils Craig-Mueller, et al. (+4)
2710 [GO] 2020―Aug―28 What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses Nirupa Gadi, Samantha C. Wu, Allison P. Spihlman, Vaishali R. Moulton
2711 [GO] 2020―Aug―28 Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2 Inmaculada Sanclemente-Alaman, Lidia Moreno-Jiménez, María Soledad Benito-Martín, Alejandro Canales-Aguirre, Jordi A. Matías-Guiu, Jorge Matías-Guiu, Ulises Gómez-Pinedo
2712 [GO] 2020―Aug―28 Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines Joana Vitte, Moïse Michel, Soraya Mezouar, Aïssatou Bailo Diallo, Asma Boumaza, Jean-Louis Mege, Benoit Desnues
2713 [GO] 2020―Aug―26 The Immune Response and Immunopathology of COVID-19 Esmaeil Mortaz, Payam Tabarsi, Mohammad Varahram, Gert Folkerts, Ian M. Adcock
2714 [GO] 2020―Aug―26 What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist Clarisa B. Palatnik-de-Sousa
2715 [GO] 2020―Aug―26 Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease Marissa Herrmann, Sophia Schulte, Nils H. Wildner, Melanie Wittner, Thomas Theo Brehm, Michael Ramharter, et al. (+4)
2716 [GO] 2020―Aug―25 Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome Massimo Caracciolo, Sebastiano Macheda, Demetrio Labate, Marco Tescione, Stefano La Scala, Eugenio Vadalà, et al. (+6)
2717 [GO] 2020―Aug―21 PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19 Giuseppe Palma, Teresa Pasqua, Giovannino Silvestri, Carmine Rocca, Paola Gualtieri, Antonio Barbieri, et al. (+5)
2718 [GO] 2020―Aug―19 The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development Sana O. Alturki, Sawsan O. Alturki, Jennifer Connors, Gina Cusimano, Michele A. Kutzler, Abdullah M. Izmirly, Elias K. Haddad
2719 [GO] 2020―Aug―18 Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19 Jun Wang, Qian Li, Yongmei Yin, Yingying Zhang, Yingying Cao, Xiaoming Lin, et al. (+4)
2720 [GO] 2020―Aug―18 Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider Juan Garcia-Revilla, Tomas Deierborg, Jose Luis Venero, Antonio Boza-Serrano
2721 [GO] 2020―Aug―18 Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury Xianyang Chen, Huifang Guo, Li Qiu, Chengdong Zhang, Qiang Deng, Qibin Leng
2722 [GO] 2020―Aug―18 Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections Hanaa Ahmed-Hassan, Brianna Sisson, Rajni Kant Shukla, Yasasvi Wijewantha, Nicholas T. Funderburg, Zihai Li, et al. (+3)
2723 [GO] 2020―Aug―14 Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using in vitro Evolution and Reverse Genetics Hatem Zayed
2724 [GO] 2020―Aug―14 Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System Pascal Urwyler, Stephan Moser, Panteleimon Charitos, Ingmar A. F. M. Heijnen, Melanie Rudin, Gregor Sommer, et al. (+5)
2725 [GO] 2020―Aug―14 The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections Yun-yu Zhang, Bi-ru Li, Bo-tao Ning
2726 [GO] 2020―Aug―13 Immunomodulatory Drugs in the Management of SARS-CoV-2 Daniel R. Burrage, Soraya Koushesh, Nidhi Sofat
2727 [GO] 2020―Aug―11 The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 Lauren A. Callender, Michelle Curran, Stephanie M. Bates, Maelle Mairesse, Julia Weigandt, Catherine J. Betts
2728 [GO] 2020―Aug―11 Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Simone Meini, Andrea Zanichelli, Rodolfo Sbrojavacca, Federico Iuri, Anna Teresa Roberts, Chiara Suffritti, Carlo Tascini
2729 [GO] 2020―Aug―11 Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection Anandita Pal, Kymberly M. Gowdy, Kenneth J. Oestreich, Melinda Beck, Saame Raza Shaikh
2730 [GO] 2020―Aug―07 Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? Chunfeng Li, Genhong Cheng
2731 [GO] 2020―Aug―07 Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response Lucas Leite Cunha, Sandro Felix Perazzio, Jamil Azzi, Paolo Cravedi, Leonardo Vidal Riella
2732 [GO] 2020―Aug―07 Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies Xuemin Guo, Lizhu Zeng, Zhen Huang, Yongjun He, Zhuojin Zhang, Zhixiong Zhong
2733 [GO] 2020―Aug―07 Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung Reinhold Förster, Henrike Fleige, Gerd Sutter
2734 [GO] 2020―Aug―07 Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay
2735 [GO] 2020―Aug―04 Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19 Roman A. Akasov, Evgeny V. Khaydukov
2736 [GO] 2020―Aug―04 Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus Isabel Kinney Ferreira de Miranda Santos, Carlos Henrique Nery Costa
2737 [GO] 2020―Jul―28 Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches Rong Dong, Zhugang Chu, Fuxun Yu, Yan Zha
2738 [GO] 2020―Jul―28 Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19? Samir Jawhara
2739 [GO] 2020―Jul―21 Mechanisms Underlying Potential Therapeutic Approaches for COVID-19 Abdelouaheb Benani, Sanae Ben Mkaddem
2740 [GO] 2020―Jul―21 The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, Aneesh Thakur
2741 [GO] 2020―Jul―21 COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella Geoffroy Méry, Olivier Epaulard, Anne-Laure Borel, Bertrand Toussaint, Audrey Le Gouellec
2742 [GO] 2020―Jul―14 Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19? Anne Geller, Jun Yan
2743 [GO] 2020―Jul―14 Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories Radu Tudor Ciornei
2744 [GO] 2020―Jul―10 Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach Anam Naz, Fatima Shahid, Tariq Tahir Butt, Faryal Mehwish Awan, Amjad Ali, Arif Malik
2745 [GO] 2020―Jul―10 A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection Ander Mayor-Ibarguren, Carmen Busca-Arenzana, Ángel Robles-Marhuenda
2746 [GO] 2020―Jul―10 The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis Inga Wessels, Benjamin Rolles, Lothar Rink
2747 [GO] 2020―Jul―10 Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper Sonu Bhaskar, Akansha Sinha, Maciej Banach, Shikha Mittoo, Robert Weissert, Joseph S. Kass, et al. (+3)
2748 [GO] 2020―Jul―10 Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies Yujun Tang, Jiajia Liu, Dingyi Zhang, Zhenghao Xu, Jinjun Ji, Chengping Wen
2749 [GO] 2020―Jul―10 The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions Anahid Jewett
2750 [GO] 2020―Jul―10 Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach Shweta Choudhary, Yashpal S. Malik, Shailly Tomar
2751 [GO] 2020―Jul―09 Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements Kosagi-Sharaf Rao, Vaddi Suryaprakash, Rajappa Senthilkumar, Senthilkumar Preethy, Shojiro Katoh, Nobunao Ikewaki, Samuel J. K. Abraham
2752 [GO] 2020―Jul―07 Pregnancy, Viral Infection, and COVID-19 Ricardo Wesley Alberca, Nátalli Zanete Pereira, Luanda Mara Da Silva Oliveira, Sarah Cristina Gozzi-Silva, Maria Notomi Sato
2753 [GO] 2020―Jul―07 Potential Fast COVID-19 Containment With Trehalose Daisy Martinon, Vanessa F. Borges, Angela C. Gomez, Kenichi Shimada
2754 [GO] 2020―Jul―07 Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option Philip F. Stahel, Scott R. Barnum
2755 [GO] 2020―Jul―03 Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19 Adam Klocperk, Zuzana Parackova, Jitka Dissou, Hana Malcova, Petr Pavlicek, Tomas Vymazal, et al. (+2)
2756 [GO] 2020―Jul―03 Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology Els Wauters, Karin Thevissen, Carine Wouters, Francesca Maria Bosisio, Frederik De Smet, Jan Gunst, et al. (+10)
2757 [GO] 2020―Jul―03 COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning Edison Ong, Mei U Wong, Anthony Huffman, Yongqun He
2758 [GO] 2020―Jul―03 Cell-Mediated Immune Responses to COVID-19 Infection Amélie Guihot, Elena Litvinova, Brigitte Autran, Patrice Debré, Vincent Vieillard
2759 [GO] 2020―Jul―03 Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies Aldo Bonaventura, Alessandra Vecchié, Tisha S. Wang, Elinor Lee, Paul C. Cremer, Brenna Carey, et al. (+6)
2760 [GO] 2020―Jul―03 Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment Felipe Saldanha-Araujo, Emãnuella Melgaço Garcez, Amandda Evelin Silva-Carvalho, Juliana Lott Carvalho
2761 [GO] 2020―Jun―30 Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19 Madalina Elena Carter-Timofte, Sofie Eg Jørgensen, Mette Ratzer Freytag, Michelle Mølgaard Thomsen, Nanna-Sophie Brinck Andersen, Ali Al-Mousawi, et al. (+2)
2762 [GO] 2020―Jun―26 Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 Rafael B. Polidoro, Robert S. Hagan, Roberta de Santis Santiago, Nathan W. Schmidt
2763 [GO] 2020―Jun―26 Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse Luiz G. Gardinassi, Camila O. S. Souza, Helioswilton Sales-Campos, Simone G. Fonseca
2764 [GO] 2020―Jun―26 Severe COVID-19: NLRP3 Inflammasome Dysregulated Daan F. van den Berg, Anje A. te Velde
2765 [GO] 2020―Jun―23 Targeting the NLRP3 Inflammasome in Severe COVID-19 Tracey L. Freeman, Talia H. Swartz
2766 [GO] 2020―Jun―23 Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies Marisa Market, Leonard Angka, Andre B. Martel, Donald Bastin, Oladunni Olanubi, Gayashan Tennakoon, et al. (+4)
2767 [GO] 2020―Jun―23 Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation? Daniela Morniroli, Maria Lorella Giannì, Alessandra Consales, Carlo Pietrasanta, Fabio Mosca
2768 [GO] 2020―Jun―23 Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients Serena Colafrancesco, Rossana Scrivo, Cristiana Barbati, Fabrizio Conti, Roberta Priori
2769 [GO] 2020―Jun―23 Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2 Rocktotpal Konwarh
2770 [GO] 2020―Jun―23 Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics? John F. Arboleda, Silvio Urcuqui-Inchima
2771 [GO] 2020―Jun―19 Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19) Ruben Manuel Luciano Colunga Biancatelli, Max Berrill, John D. Catravas, Paul E. Marik
2772 [GO] 2020―Jun―19 Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis Adonis Sfera, Carolina Osorio, Nyla Jafri, Eddie Lee Diaz, Jose E. Campo Maldonado
2773 [GO] 2020―Jun―18 Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? Martina Severa, Cinthia Farina, Marco Salvetti, Eliana Marina Coccia
2774 [GO] 2020―Jun―16 Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 Luis F. García
2775 [GO] 2020―Jun―16 The COVID-19 Cytokine Storm; What We Know So Far Dina Ragab, Haitham Salah Eldin, Mohamed Taeimah, Rasha Khattab, Ramy Salem
2776 [GO] 2020―Jun―16 Solid Organ Transplantation During the COVID-19 Pandemic Hedong Zhang, Helong Dai, Xubiao Xie
2777 [GO] 2020―Jun―16 Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids Yi Miao, Lei Fan, Jian-Yong Li
2778 [GO] 2020―Jun―11 Activation of TRL-7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy Konstantinos Poulas, Konstantinos Farsalinos, Charilaos Zanidis
2779 [GO] 2020―Jun―11 Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm Jesus Gonzalez-Rubio, Carmen Navarro-Lopez, Elena Lopez-Najera, Ana Lopez-Najera, Lydia Jimenez-Diaz, Juan D. Navarro-Lopez, Alberto Najera
2780 [GO] 2020―Jun―10 Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells Mahmood Yaseen Hachim, Saba Al Heialy, Ibrahim Yaseen Hachim, Rabih Halwani, Abiola C. Senok, Azzam A. Maghazachi, Qutayba Hamid
2781 [GO] 2020―Jun―05 Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline Muhammad Abbas Abid, Loren Nunley, Muhammad Bilal Abid
2782 [GO] 2020―Jun―05 The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe? Zaid Abassi, Yara Knaney, Tony Karram, Samuel N. Heyman
2783 [GO] 2020―May―29 COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase Scott B. Halstead, Ramesh Akkina
2784 [GO] 2020―May―29 Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation Marco Cardone, Masahide Yano, Amy S. Rosenberg, Montserrat Puig
2785 [GO] 2020―May―28 Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate? Luciano Mutti, Francesca Pentimalli, Giovanni Baglio, Patrizia Maiorano, Rita Emilena Saladino, Pierpaolo Correale, Antonio Giordano
2786 [GO] 2020―May―28 Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm Piero Ruscitti, Onorina Berardicurti, Paola Di Benedetto, Paola Cipriani, Annamaria Iagnocco, Yehuda Shoenfeld, Roberto Giacomelli
2787 [GO] 2020―May―28 Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection? Harald Murck
2788 [GO] 2020―May―28 Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing? Athar Khalil, Amina Kamar, Georges Nemer
2789 [GO] 2020―May―28 Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? Jean-Michel Sallenave, Loïc Guillot
2790 [GO] 2020―May―27 Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome? A. S. Smiline Girija, Esaki M. Shankar, Marie Larsson
2791 [GO] 2020―May―27 Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health Ícaro Raony, Camila Saggioro de Figueiredo, Pablo Pandolfo, Elizabeth Giestal-de-Araujo, Priscilla Oliveira-Silva Bomfim, Wilson Savino
2792 [GO] 2020―May―27 Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs Stefania Scala, Roberto Pacelli
2793 [GO] 2020―May―19 Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 Adnan Shah
2794 [GO] 2020―May―19 MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy Guido Moll, Norman Drzeniek, Julian Kamhieh-Milz, Sven Geissler, Hans-Dieter Volk, Petra Reinke
2795 [GO] 2020―May―15 Interferon-α2b Treatment for COVID-19 Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, et al. (+4)
2796 [GO] 2020―May―15 Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy? Farha Naz, Mohd Arish
2797 [GO] 2020―May―15 Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art Gabriel Siracusano, Claudia Pastori, Lucia Lopalco
2798 [GO] 2020―May―12 Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS Nora Möhn, Refik Pul, Christoph Kleinschnitz, Harald Prüss, Torsten Witte, Martin Stangel, Thomas Skripuletz
2799 [GO] 2020―May―12 Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection Yanwen Liang, Mong-Lien Wang, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ping Yang, Wei-Yi Lai, et al. (+5)
2800 [GO] 2020―May―08 Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection Heinz Fischer, Erwin Tschachler, Leopold Eckhart
2801 [GO] 2020―May―08 Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? Camila Covián, Angello Retamal-Díaz, Susan M. Bueno, Alexis M. Kalergis
2802 [GO] 2020―May―07 Coronavirus Disease (COVID-19-SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection? Hellas Cena, Marcello Chieppa
2803 [GO] 2020―May―01 Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) Bo Diao, Chenhui Wang, Yingjun Tan, Xiewan Chen, Ying Liu, Lifen Ning, et al. (+9)
2804 [GO] 2020―Apr―30 Potential SARS-CoV-2 Preimmune IgM Epitopes Velizar Shivarov, Peter K. Petrov, Anastas D. Pashov
2805 [GO] 2020―Apr―24 Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control Cheryl Yi-Pin Lee, Raymond T. P. Lin, Laurent Renia, Lisa F. P. Ng
2806 [GO] 2020―Apr―21 Commentary: Origin and evolution of pathogenic coronaviruses Shun Adachi, Takaaki Koma, Naoya Doi, Masako Nomaguchi, Akio Adachi
[  < Back ]   [1]  [2] 

2806 Results       Page 2


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.028 sec